fluorodeoxyglucose f18 has been researched along with Parkinson Disease in 294 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (2.38) | 18.7374 |
| 1990's | 39 (13.27) | 18.2507 |
| 2000's | 77 (26.19) | 29.6817 |
| 2010's | 128 (43.54) | 24.3611 |
| 2020's | 43 (14.63) | 2.80 |
| Authors | Studies |
|---|---|
| Cho, K; Jeong, JE; Jeong, YJ; Kang, DY; Kim, WG; Yoon, HJ | 1 |
| Leenders, KL; Meles, SK; Oertel, WH | 1 |
| Drzezga, A; Eggers, C; Greuel, A; Jessen, F; Kalbe, E; Krohm, F; Maier, F; Ophey, A; Timmermann, L; Tittgemeyer, M | 1 |
| Arnaldi, D; Barisione, E; Bauckneht, M; Benedetti, L; Biassoni, E; Chiola, S; D'amico, F; Donegani, MI; Gianmario, S; Lanfranchi, F; Mancini, R; Miceli, A; Morbelli, S; Nobili, F; Orso, B; Pardini, M | 1 |
| Ko, JH; Strafella, AP | 1 |
| Depierreux, F; Mackels, L; Moïse, M | 1 |
| Golan, H; Shalom, E; Volkov, O | 1 |
| Jeon, B; Kim, H; Kim, YK; Lee, JY; Nam, H; Shin, JH; Yoo, D; Yoon, EJ | 1 |
| Eidelberg, D; Ležaić, L; Perovnik, M; Rebec, E; Rus, T; Studen, A; Tang, CC; Tomše, P; Trošt, M | 1 |
| Chen, Y; Ge, J; Jiang, J; Li, L; Lin, W; Sun, X; Wu, P; Yang, L; Zhang, Q; Zuo, C | 1 |
| Ahlskog, JE; Ali, F; Botha, H; Carlos, AF; Clark, HM; Coon, EA; Dickson, DW; Josephs, KA; Koga, S; Lowe, V; Pham, NTT; Sekiya, H; Trejo-Lopez, JA; Whitwell, JL | 1 |
| Chen, MJ; Ge, JJ; Jiao, FY; Ju, ZZ; Li, L; Li, XY; Liang, XN; Liu, FT; Lu, JY; Luo, JF; Sun, YM; Wang, J; Wu, JJ; Wu, P; Yen, TC; Zuo, C | 1 |
| Biehl, M; de Vries, GJ; Janzen, A; Leenders, KL; Meles, SK; Oertel, WH; Reesink, FE; Renken, RJ; van Veen, R | 1 |
| Booth, S; Ko, JH; Lee, CS; Park, KW | 1 |
| Dhawan, V; Eidelberg, D; Rus, T; Schindlbeck, KA; Tang, CC; Trošt, M; Vo, A | 1 |
| Arnaldi, D; Bauckneht, M; Camedda, R; Chiaravalloti, A; Donniaquio, A; Famà, F; Giberti, A; Giorgetti, L; Izzi, F; Leenders, KL; Liguori, C; Massa, F; Mattioli, P; Meles, SK; Mercuri, NB; Morbelli, S; Nobili, F; Orso, B; Pardini, M; Placidi, F; Schillaci, O; Spanetta, M; Vállez García, D | 1 |
| Al-Fatly, B; Anton-Rodriguez, JM; Carter, SF; Gerhard, A; Herholz, K; Hinz, R; Kobylecki, C; Kübler, D; McDonald, KR; Thompson, JC | 1 |
| Li, J; Lu, J; Mei, S; Nie, B; Qu, H; Song, T; Wu, T; Zang, Z; Zhang, Y | 1 |
| Arnaldi, D; Bauckneht, M; Biassoni, E; Brugnolo, A; D'Amico, F; Girtler, N; Kreshpa, W; Massa, F; Mattioli, P; Morbelli, S; Nobili, F; Orso, B; Pardini, M; Tinazzi, M | 1 |
| Csoti, I; Drzezga, A; Eggers, C; Greuel, A; Hoock, M; Jessen, F; Kaur, R; Maier, F; Schwartz, F; Tahmasian, M; Timmermann, L; van Eimeren, T | 1 |
| Bi, L; Cui, M; Hou, Y; Huang, G; Jin, H; Li, Z; Liu, Y; Qiu, Y; Yang, M; Ye, P; Yee Tong, HH | 1 |
| Carli, G; Janzen, A; Kogan, RV; Leenders, KL; Meles, SK; Oertel, WH; Perani, D; Sittig, E | 1 |
| Carli, G; de Jong, BM; Ferini-Strambi, L; Galbiati, A; Leenders, KL; Meles, SK; Padovani, A; Perani, D; Pilotto, A; Reesink, FE | 1 |
| Bouillot, C; Chaib, S; Depoortere, R; Levigoureux, E; Newman-Tancredi, A; Vidal, B; Zimmer, L | 1 |
| Jamšek, J; Mlakar, J; Rus, T; Trošt, M | 1 |
| Baekelandt, V; Casteels, C; Devrome, M; Koole, M; Van der Perren, A; Van Laere, K | 1 |
| Chung, SJ; Kim, H; Kim, JS; Lee, CS; Moon, H; Oh, JS; Oh, M | 1 |
| Del Alamo, M; García-Cañamaque, L; Hernández, F; Kogan, RV; Leenders, KL; Martinez-Fernandez, R; Obeso, JA; Pineda-Pardo, JA; Rodriguez-Rojas, R; Sanchez-Catasus, CA | 1 |
| Choi, H; Kim, YK; Lee, DS; Lee, JY; Yoon, EJ | 1 |
| Arnaldi, D; Leenders, KL; Meles, SK; Morbelli, S; Nobili, F; Obeso, JA; Pagani, M; Renken, RJ; Rodríguez-Oroz, MC; Teune, LK; van Laar, T | 1 |
| Irishina, YA; Kataeva, GV; Khomenko, IG; Kropotov, JD; Pronina, MV; Susin, DS | 1 |
| Aracil-Bolaños, I; Bejr-Kasem, H; Camacho, V; Carrió, I; Gironell, A; Horta-Barba, A; Kulisevsky, J; Marín-Lahoz, J; Martínez-Horta, S; Pagonabarraga, J; Pascual-Sedano, B; Pérez-Pérez, J; Sampedro, F | 1 |
| Drzezga, A; Eggers, C; Greuel, A; Hammes, J; Maier, F; Ruppert, MC; Schwartz, F; Stürmer, S; Tahmasian, M; Timmermann, L; Tittgemeyer, M; van Eimeren, T | 1 |
| Brumberg, J; Canessa, A; Isaias, IU; Marotta, G; Palmisano, C; Pezzoli, G; Pozzi, NG; Volkmann, J | 1 |
| Caminiti, SP; Carli, G; Casoni, F; Ferini-Strambi, L; Galbiati, A; Marelli, S; Padovani, A; Perani, D | 1 |
| Eidelberg, D; Jensterle, L; Ležaić, L; Pirtošek, Z; Popović, M; Rus, T; Stokin, CL; Tang, CC; Tomše, P; Trošt, M | 1 |
| Eggers, C; Eidelberg, D; Fink, GR; Holtbernd, F; Ma, Y; Oh, A; Spetsieris, P; Tang, CC; Timmermann, L | 1 |
| Cheon, M; Ha, SW; Kim, DH; Kim, SM; Kyeong, S; Yoo, J | 1 |
| Gao, S; Li, X; Zhang, B; Zhao, P | 1 |
| Arnaldi, D; Biehl, M; de Jong, BM; de Vries, GJ; Gurvits, V; Kogan, RV; Leenders, KL; Meles, SK; Raffa, S; Renken, RJ; Rodriguez-Oroz, MC; Rodriguez-Rojas, R; van Veen, R | 1 |
| Eidelberg, D; Spetsieris, PG | 1 |
| Feng, Z; Jiang, L; Li, P; Shao, H; Shi, X; Wang, X | 1 |
| Dondaine, T; Drapier, D; Drapier, S; Duprez, J; Guillery, M; Houvenaghel, JF; Le Jeune, F; Riou, A; Robert, G; Sauleau, P; Verin, M | 1 |
| De Vincentis, G; Frantellizzi, V; Madeddu, G; Nuvoli, S; Palumbo, B; Spanu, A; Stazza, ML; Tanda, G | 1 |
| Barker, RA; Brooks, DJ; Burn, DJ; Duncan, GW; Firbank, MJ; Khoo, TK; Lawson, RA; Maxwell, RJ; O'Brien, JT; Petrides, GS; Yarnall, AJ | 1 |
| Artiko, V; Brajkovic, L; Castiglioni, I; Gallivanone, F; Jecmenica-Lukic, M; Jesic, A; Kostic, V; Odalovic, S; Radovic, B; Sobic-Saranovic, D; Stefanova, E; Stojiljkovic, M; Trajkovic, G | 1 |
| Dhawan, V; Eidelberg, D; Grmek, M; Jensterle, L; Ma, Y; Peng, S; Pirtošek, Z; Tomše, P; Trošt, M; Zaletel, K | 1 |
| Ding, J; Jiang, S; Li, J; Li, T; Wang, X; Yuan, Y; Zhang, J; Zhang, K; Zhang, L; Zhu, L | 1 |
| Alberici, A; Borroni, B; Caminiti, SP; Cosseddu, M; Padovani, A; Paghera, B; Perani, D; Pilotto, A; Premi, E; Presotto, L; Sala, A; Turrone, R | 1 |
| Adriaanse, SM; Booij, J; Depboylu, C; Heinen, L; Höffken, H; Kesper, K; Leenders, KL; Luster, M; Mayer, G; Meles, SK; Oertel, WH; Overeem, S; Pijpers, A; Reesink, FE; Reetz, K; Renken, RJ; Sittig-Wiegand, E; Teune, LK; Vadasz, D; van Laar, T | 1 |
| Ding, J; Jiang, S; Li, T; Tong, Q; Wang, J; Wang, M; Xu, Q; Yuan, Y; Zhang, K; Zhang, L | 1 |
| Barker, RA; Foltynie, T; Lao-Kaim, NP; Li, W; Loane, C; Martín-Bastida, A; Paul, G; Piccini, P; Politis, M; Roussakis, AA; Valle-Guzman, N; Widner, H | 1 |
| Annarumma, I; Brunetti, A; De Lucia, N; De Michele, G; De Rosa, A; Esposito, M; Manganelli, F; Pappatà, S; Peluso, S; Russo, P | 1 |
| Drzezga, A; Eggers, C; Maier, F; Meyer, TD; Rochhausen, L; Samea, F; Schnorrenberg, KL; Schwartz, F; Seemiller, J; Sorg, C; Tahmasian, M; Timmermann, L; van Eimeren, T; Zarei, M | 1 |
| Alberici, A; Borroni, B; Padovani, A; Paghera, B; Paola Caminiti, S; Perani, D; Pilotto, A; Premi, E; Presotto, L; Turrone, R | 1 |
| Eidelberg, D; Ge, J; Guan, Y; Ma, Y; Peng, S; Wang, J; Wu, J; Wu, P; Zhang, H; Zuo, C | 1 |
| Claassen, DO; Deutch, AY; Donahue, MJ; Kessler, RM; Petersen, KJ; Smith, CT; Stark, AJ; Trujillo, P; van Wouwe, NC; Zald, DH | 1 |
| Azulay, JP; Chawki, MB; Eusebio, A; Guedj, E; Klesse, E; Verger, A; Witjas, T | 1 |
| Agosta, F; Altomare, D; Arbizu, J; Boccardi, M; Bouwman, F; Drzezga, A; Festari, C; Gandolfo, F; Garibotto, V; Nestor, P; Nobili, F; Orini, S; Walker, Z | 1 |
| Ge, JJ; Liu, FT; Ma, Y; Wang, J; Wu, JJ; Wu, P; Zuo, CT | 1 |
| Baba, T; Gang, M; Hirayama, K; Hosokai, Y; Ishioka, T; Mori, E; Nishio, Y; Suzuki, K; Takeda, A; Uchiyama, M; Yokoi, K | 1 |
| Bravo, JJ; Cabello, JP; Corrales, MJ; Gallardo, MJ; León, A; Talavera, MP; Torres-Donaire, J; Vaamonde-Gamo, J | 1 |
| Anderson, T; Chen, L; Ge, JJ; Liu, FT; Tang, YL; Wang, J; Wu, L; Yu, H; Yu, WB; Zhao, J; Zuo, CT | 1 |
| Berg, D; Blum, D; la Fougère, C; Liepelt-Scarfone, I; Maetzler, W; Pilotto, A; Reimold, M | 1 |
| Drapier, D; Drapier, S; Grandjean, D; Houvenaghel, JF; Jeune, FL; N'Diaye, K; Péron, J; Robert, G; Stirnimann, N; Vérin, M | 1 |
| Dhawan, V; Eidelberg, D; Ma, Y; Peng, S; Pirtošek, Z; Tomše, P; Trošt, M; Zaletel, K | 1 |
| Aljuaid, M; Bybel, B; Goertzen, AL; Kang, DY; Katako, A; Kim, SM; Ko, JH; Lee, CS; Levin, D; Shelton, P; Yoon, HJ | 1 |
| Andrews, RD; Cedarbaum, JM; Evans, KC; Even-Sapir, E; Giladi, N; Lerman, H; Lukic, A; Matthews, DC; Mirelman, A; Strother, SC; Wernick, MN | 1 |
| Chu, JS; Han, CL; Liu, TH; Liu, YP; Ma, HZ; Meng, FG; Wang, KL; Xia, XT; Zang, YZ; Zhao, XB | 1 |
| Lafontaine, AL; Mitchell, T; Monchi, O; Paquette, C; Potvin-Desrochers, A; Thiel, A | 1 |
| Ge, J; Guan, Y; Huang, Z; Jiang, C; Li, L; Li, M; Wang, J; Wu, J; Wu, P; Xu, Q; Yu, H; Zuo, C | 1 |
| Arnaldi, D; Giuliani, A; Janzen, A; Jonsson, C; Leenders, KL; Mayer, G; Meles, SK; Morbelli, S; Nobili, F; Oertel, WH; Pagani, M; Renken, RJ | 1 |
| Arnaldi, D; Leenders, KL; Manzanera, OM; Maurits, NM; Meles, SK; Morbelli, S; Nobili, F; Obeso, J; Oroz, MR; Pagani, M; Renken, RJ | 1 |
| Apetz, N; Aswendt, M; Drzezga, A; Endepols, H; Kordys, E; Mang, B; Neumaier, B; Simon, M; Timmermann, L; Wiedermann, D | 1 |
| Bastianello, M; Biafore, F; Depetris, TS; Peralta, C | 1 |
| Botas-Peñin, A; Dacosta-Aguayo, R; Delgado-Alvarado, M; Gago, B; Jimenez-Urbieta, H; Martin-Bastida, A; Molinet-Dronda, F; Navalpotro-Gomez, I; Quiroga-Varela, A; Rodriguez-Oroz, MC | 1 |
| Beuthien-Baumann, B; Hausbrand, D; Hermann, A; Hermann, W; Kotzerke, J; Löhle, M; Mende, J; Oehme, L; Reichmann, H; Storch, A; van den Hoff, J; Wolz, M | 1 |
| Dorfman, BJ; Henchcliffe, C; Huang, C; Maniscalco, JS; Nirenberg, MJ; Piboolnurak, P; Ravdin, LD; Severt, L; Solnes, L | 1 |
| Benedí, J; Delgado, M; Fernández-Ruiz, J; García-Arencibia, M; García-García, L; Gómez del Rio, MA; Iglesias, I; Pozo, MA; Sánchez-Reus, MI | 1 |
| Guan, Y; Ma, Y; Peng, S; Wang, J; Wu, P; Zhang, H; Zuo, C | 1 |
| Dhawan, V; Eidelberg, D; Ko, JH; Ma, Y; Mattis, PJ; Niethammer, M; Tang, CC | 1 |
| Dhawan, V; Eidelberg, D; Feigin, A; Ma, Y; Mattis, P; Peng, S; Spetsieris, PG | 1 |
| Brooks, DJ; Gill, SS; Hotton, GR; Javed, S; Patel, NK; Pavese, N | 1 |
| Chung, SJ; Im, KC; Kim, J; Kim, JS; Kim, MJ; Lee, JH; Lee, MC; Park, HK | 1 |
| Dondaine, T; Drapier, D; Drapier, S; Houvenaghel, JF; Le Jeune, F; Lozachmeur, C; Millet, B; Péron, J; Robert, G; Sauleau, P; Travers, D; Vérin, M | 1 |
| Dhawan, V; Eidelberg, D; Feigin, A; Gagnon, JF; Holtbernd, F; Ma, Y; Montplaisir, J; Postuma, RB; Soucy, JP; Tang, CC; Vendette, M | 1 |
| Loane, C; Niccolini, F; Politis, M | 1 |
| Lewitt, PA; Mouradian, MM | 1 |
| Eggers, C; Kracht, L; Pedrosa, DJ; Schwartz, F; Timmermann, L | 1 |
| Arbizu, J; Clavero, P; García-Eulate, R; García-García, D; Gasca-Salas, C; González-Redondo, R; Obeso, JA; Rodríguez-Oroz, MC; Zubieta, JL | 1 |
| de Jong, BM; Dierckx, RA; Leenders, KL; Renken, RJ; Roerdink, JB; Teune, LK; van Osch, MJ; Willemsen, AT | 1 |
| Ahmed, I; Aman, Y; Brooks, DJ; Chetelat, G; Edison, P; Fan, Z; Landeau, B; Ray Chaudhuri, K | 1 |
| Arnaldi, D; Buschiazzo, A; De Carli, F; Famà, F; Ferrara, M; Morbelli, S; Nobili, F; Picco, A | 1 |
| Choi, CG; Chung, SJ; Kim, HS; Kim, JS; Kim, SJ; Lee, CS; Oh, J; Yoon, RG | 1 |
| Buchpiguel, CA; Hespanhol, R; Leite, J | 1 |
| Hosokai, Y; Mori, E; Nishio, Y; Takeda, A; Uchiyama, M; Yokoi, K | 1 |
| Leenders, KL; Mudali, D; Renken, RJ; Roerdink, JB; Teune, LK | 1 |
| Chung, M; Huh, R; Jang, SJ; Kim, HS; Kim, JS; Kim, WC; Kim, YJ; Ma, HI; Park, YS | 1 |
| Eggers, C; Eidelberg, D; Fink, GR; Holtbernd, F; Kracht, L; Ma, Y; Peng, S; Schwartz, F; Tang, CC; Timmermann, L | 1 |
| Goldstein, DS; Holmes, C; Kopin, IJ; Mash, DC; Sharabi, Y; Sidransky, E; Stefani, A; Sullivan, P | 1 |
| Defebvre, L; Delval, A; Devos, D; Duhamel, A; Dujardin, K; Hossein-Foucher, C; Le Jeune, F; Lenfant, P; Lopes, R; Moreau, C; Semah, F; Tard, C | 1 |
| Boecker, H; Drzezga, AE; Götz, J; Granert, O; Häussermann, P; Kurz, A; Perneczky, R; van Eimeren, T | 1 |
| Chung, SJ; Kim, HW; Kim, JS; Lee, CS; Lee, SJ; Oh, JS; Oh, M; Oh, SJ | 1 |
| Defebvre, L; Delval, A; Demailly, F; Dujardin, K; Moreau, C; Semah, F; Tard, C | 1 |
| Clavero, P; García-García, D; Gasca-Salas, C; Obeso, JA; Rodríguez-Oroz, MC | 1 |
| Dondaine, T; Drapier, D; Drapier, S; Haegelen, C; Jannin, P; Le Jeune, F; Ory, S; Péron, J; Philippot, P; Sauleau, P; Vérin, M; Vicente, S | 1 |
| Beuthien-Baumann, B; Kotzerke, J; Löhle, M; Mende, J; Oehme, L; Reichmann, H; Storch, A; van den Hoff, J; Wolz, M | 1 |
| Chen, HJ; Ding, J; Jiang, SM; Li, TN; Tong, Q; Wang, JW; Wang, M; Xu, QR; Yuan, YS; Zhang, KZ; Zhang, L | 1 |
| Ahn, BJ; Joo, JJ; Kwon, KY; Park, J | 1 |
| Atkinson, R; Brooks, DJ; Edison, P; Fan, Z; Femminella, GD; Ninan, S | 1 |
| Ding, Z; Ge, J; Guo, S; Liu, F; Liu, Z; Tang, Y; Wang, J; Wang, Y; Wu, J; Wu, P; Zuo, C | 1 |
| Eidelberg, D; Fujita, K; Ma, Y; Mattis, PJ; Peng, S; Sako, W; Skidmore, FM; Uluğ, AM; Vo, A | 1 |
| Accardo, J; Arnaldi, D; Brugnolo, A; Buschiazzo, A; de Carli, F; Ferrara, M; Girtler, N; Morbelli, S; Nobili, F; Pagani, M; Picco, A | 1 |
| Eggers, C; Ellereit, AL; Fink, GR; Herz, DM; Kracht, L; Maier, F; Prigatano, GP; Rochhausen, L; Tahmasian, M; Tang, CC; Timmermann, L; Williamson, KL | 1 |
| Albert, NL; Bartenstein, P; Boetzel, K; Cumming, P; Deutschländer, A; Gildehaus, FJ; la Fougère, C; Xiong, G | 1 |
| Goldstein, DS; Holmes, C; Jinsmaa, Y; Kopin, IJ; Sharabi, Y; Sullivan, P | 1 |
| Agorastos, S; Bimpisidis, Z; Cenci, MA; Dewey, SL; Eidelberg, D; Lerner, RP; Scherrer, S | 1 |
| Aminian, K; Cho, SS; Houle, S; Lang, AE; Li, C; Strafella, AP | 1 |
| Liu, YT; Mao, CY; Shi, CH; Wu, P; Xu, YM; Yang, J; Zhang, SY; Zhuang, ZP; Zuo, CT | 1 |
| de Jong, BM; Dierckx, RA; Leenders, KL; Meles, SK; Teune, LK | 1 |
| Chen, T; Chen, Y; Guo, Z; Wang, R; Xu, B; Zhang, J; Zhu, H | 1 |
| Auffret, M; Drapier, S; Houvenaghel, JF; Le Jeune, F; Maurus, A; Robert, GH; Sauleau, P; Vérin, M | 1 |
| Aoki, M; Baba, T; Hasegawa, T; Hirayama, K; Hosokai, Y; Kikuchi, A; Mori, E; Nishio, Y; Suzuki, K; Takeda, A | 1 |
| Chung, SJ; Kim, HW; Kim, JS; Lee, SJ; Oh, JS; Oh, M; Oh, SJ | 1 |
| Dhawan, V; Eidelberg, D; Grmek, M; Jensterle, L; Ma, Y; Rep, S; Tomše, P; Trošt, M; Zaletel, K | 1 |
| Chaudhuri, KR; Niccolini, F; Pagano, G; Politis, M; Polychronis, S; Wilson, H; Yousaf, T | 1 |
| Cao, C; Li, D; Sun, B; Zhan, S; Zhang, H; Zhang, J; Zhang, X; Zuo, C | 1 |
| Duan, Z; Feng, T; Li, W; Lu, L; Ouyang, Q; Wang, Y; Xiang, W | 1 |
| Criscuolo, C; De Martino, M; De Michele, G; De Rosa, A; Filla, A; Giordano, IA; Mancini, P; Pappatà, S | 1 |
| Baudrexel, S; Heiss, WD; Hilker, R; Hoevels, M; Kracht, LW; Roggendorf, J; Sturm, V; Voges, J; Weber, T | 1 |
| Choi, CG; Chung, SJ; Kim, JS; Kwon, KY; Lee, MC | 2 |
| Chung, SJ; Im, KC; Kim, JS; Kim, MJ; Lee, JH; Lee, MC; Oh, SJ; Park, HK | 1 |
| An, YS; Lee, PH; Yong, SW | 1 |
| Gao, S; Li, ZG; Ma, AJ; Pan, XD; Zhang, BS | 1 |
| Baudrexel, S; Haarer, M; Heiss, WD; Hilker, R; Kalbe, E; Kessler, J; Klein, JC; Sturm, V; Voges, J; Weber, T | 1 |
| Aalto, S; Bergman, J; Brück, A; Marttila, R; Rauhala, E; Rinne, JO | 1 |
| Dhawan, V; Eidelberg, D; Kaplitt, MG; Lin, T; Pourfar, M; Tang, C | 1 |
| Abe, N; Fujii, T; Fukuda, H; Hirayama, K; Hosokai, Y; Ishioka, T; Itoyama, Y; Mori, E; Nishio, Y; Suzuki, K; Takahashi, S; Takeda, A | 1 |
| Dhawan, V; Eidelberg, D; Ma, Y; Spetsieris, PG | 1 |
| Aanerud, J; Borghammer, P; Cumming, P; Förster, S; Gjedde, A | 1 |
| Berg, D; Gaenslen, A; Godau, J; Herbst, H; Liepelt, I; Maetzler, W; Reimold, M; Reischl, G | 1 |
| Jeon, BS; Kim, HJ; Kim, JS; Lee, EK; Lee, JY; Lim, JY; Park, SS | 1 |
| Farrer, MJ; Hattori, N; Imai, H; Inoue, Y; Ishii, K; Ishiwata, K; Kachergus, JM; Kitagawa, M; Kono, S; Mizoguchi, K; Mizuno, Y; Nishioka, K; Obi, T; Ross, OA; Takanashi, M | 1 |
| Berti, V; De Cristofaro, MT; Formiconi, AR; Marini, P; Mungai, F; Pellicanò, G; Polito, C; Pupi, A; Ramat, S; Sorbi, S; Vanzi, E | 1 |
| Alvarez, L; Artieda, J; Bhatia, K; Day, B; Guridi, J; Jahanshahi, M; Lopez, G; Macias, R; Obeso, JA; Pavon, N; Pedroso, I; Pinto, S; Rodríguez, R; Rodriguez-Diaz, M; Rodríguez-Oroz, MC; Rothwell, JC; Swayne, O; Talelli, P; Tejeiro, J; Wilkinson, L | 1 |
| Huang, Y; Jiang, X; Tang, A; Wik, G; Zhuo, Y | 1 |
| Bourguignon, A; Drapier, D; Drapier, S; Garin, E; Haegelen, C; Le Jeune, F; Malbert, CH; Mesbah, H; Millet, B; Péron, J; Sauleau, P; Travers, D; Vérin, M | 1 |
| Bhatia, KP; Brooks, DJ; Hotton, G; Khan, NL; Lees, AJ; Moore, RY; Pavese, N; Piccini, P; Quinn, NP; Scherfler, C; Wood, NW | 1 |
| Alsop, D; Dyke, JP; Eidelberg, D; Feigin, A; Huang, C; Ma, Y; Pan, H | 1 |
| Barker, RA | 1 |
| Dhawan, V; Eidelberg, D; Poston, KL; Tang, CC | 1 |
| Baudrexel, S; Diederich, NJ; Eggers, C; Heiss, WD; Hilker, R; Hohmann, C; Kalbe, E; Klein, JC; Vollmar, S; Weisenbach, S | 1 |
| Drapier, S; Garin, E; Grandjean, D; Haegelen, C; Le Jeune, F; Millet, B; Péron, J; Vérin, M | 1 |
| Dondaine, T; Drapier, D; Drapier, S; Haegelen, C; Le Jeune, F; Millet, B; Péron, J; Reymann, JM; Rouaud, T; Sauleau, P; Vérin, M | 1 |
| Cirillo, M; Giordano, A; Marcuccio, L; Russo, A; Tedeschi, G; Tessitore, A | 1 |
| Brusa, L; Ceravolo, R; Galati, S; Pierantozzi, M; Stanzione, P; Stefani, A | 1 |
| Jeong, Y; Lee, MS; Lyoo, CH; Rinne, JO; Ryu, YH | 1 |
| Bressman, S; Brüggemann, N; Condefer, K; Dhawan, V; Hagenah, J; Klein, C; Kornreich, R; Ozelius, L; Palmese, C; Pastores, G; Roe, A; Sathe, S; Saunders-Pullman, R; Stanley, K; Tagliati, M | 1 |
| Hilker, R | 1 |
| Go, SM; Kim, EJ; Na, DL; Roh, JH; Seo, SW; Suh, MK | 1 |
| Schwarz, J | 1 |
| Antonini, A; Dhawan, V; Eidelberg, D; Hirano, S; Isaias, IU; Ma, Y; Mure, H; Tang, CC | 1 |
| Aalto, S; Haaparanta, M; Jokinen, P; Någren, K; Parkkola, R; Rinne, JO; Rokka, J; Röyttä, M; Savisto, N; Scheinin, N | 1 |
| Kim, HS; Lee, MS; Lim, HS; Lyoo, CH; Nam, CM; Rinne, JO; Ryu, YH | 1 |
| Haas, RH; Le, T; Markham, J; Perlmutter, JS; Powers, WJ; Videen, TO | 1 |
| Cole, MH; Coyne, T; Kerr, G; Silburn, P; Wilcox, RA; Wong, D | 1 |
| Au, WL; Calne, DB; Cragg, J; de la Fuente-Fernández, R; Kuramoto, L; Lee, CS; Mak, E; McCormick, S; McKenzie, J; Ramachandiran, N; Ruth, TJ; Schulzer, M; Sossi, V; Stoessl, AJ | 1 |
| Fukuda, H; Hirayama, K; Hosokai, Y; Ishioka, T; Itoyama, Y; Mori, E; Nishio, Y; Sawada, Y; Suzuki, K; Takahashi, S; Takeda, A | 2 |
| Bahri, MA; Degueldre, C; Garraux, G; Kaschten, B; Lemaire, C; Salmon, E | 1 |
| Albin, RL; Bohnen, NI; Frey, KA; Giordani, B; Koeppe, RA; Kuhl, DE; Minoshima, S | 1 |
| Arnaldi, D; Brugnolo, A; Campus, C; Ferrara, M; Mazzei, D; Mehrdad, N; Morbelli, S; Nobili, F; Rodriguez, G; Sambuceti, G | 1 |
| Aarsland, D; Amboni, M; Barone, P; Bronnick, K; Brunetti, A; Caprio, MG; De Michele, G; Erro, R; Longo, K; Pappatà, S; Pellecchia, MT; Salvatore, M; Santangelo, G; Vicidomini, C; Vitale, C | 1 |
| Aasly, JO; Armaly, J; Furay, AR; Hasegawa, K; Leverenz, JB; Shi, M; Sossi, V; Stoessl, AJ; Uitti, RJ; Wang, Y; Wszolek, ZK; Yokoyama, T; Zabetian, CP; Zhang, J | 1 |
| Gao, S; Zhang, B; Zhao, P | 1 |
| Bauer, S; Berg, D; Dietzel, E; Liepelt-Scarfone, I; Liscic, RM; Maetzler, W; Reimold, M; Srulijes, K | 1 |
| Anders, S; Binkofski, F; Klein, C; Münte, T; Pohl, A; Pramstaller, P; Sack, B | 1 |
| Halldin, C; Varrone, A | 1 |
| Dhawan, V; Eckert, T; Eidelberg, D; Fahn, S; Frucht, S; Poston, KL; Tang, CC; Vonsattel, JP | 1 |
| Eidelberg, D; Feigin, A; Niethammer, M | 1 |
| Comi, G; Cursi, M; Franzin, A; Garibotto, V; Giovannini, E; Leocani, L; Panzacchi, A; Perani, D; Picozzi, P; Spagnolo, F; Volonté, MA | 1 |
| Biersack, HJ; Bippus, R; Bucerius, J; Fayad, ZA; Gündisch, D; Mani, V; Manka, C; Mottaghy, FM; Rudd, JH; Schmaljohann, J; Wüllner, U | 1 |
| Cooke, JP | 1 |
| Berti, V; Borghammer, P; De Cristofaro, MT; De Leon, M; Mosconi, L; Polito, C; Pupi, A; Ramat, S; Sorbi, S; Vanzi, E | 1 |
| Huang, T; Liang, X; Shi, X; Tang, G; Wang, H; Zhang, X | 1 |
| Arbizu, J; Clavero, P; Garcia-Garcia, D; Gasca Salas, C; Gonzalez-Redondo, R; Lamet, I; Obeso, JA; Rodriguez-Oroz, MC | 1 |
| Chiou, SM; Hsu, YT; Huang, HY; Kao, CH; Tsai, CH; Tsai, MC; Wu, YC | 1 |
| Amtage, F; Buchert, R; Hellwig, B; Hellwig, S; Kreft, A; Meyer, PT; Rijntjes, M; Spehl, TS; Tüscher, O; Vach, W; Weber, WA; Weiller, C; Winkler, C; Winz, OH | 1 |
| Dhawan, V; Eidelberg, D; Ma, Y; Spetsieris, P; Tang, CC | 1 |
| Baggio, HC; Bargalló, N; Ibarretxe-Bilbao, N; Junqué, C; Martí, MJ; Sala-Llonch, R; Segura, B; Tolosa, E; Valldeoriola, F; Vendrell, P | 1 |
| Guo, XJ; Li, DC; Ma, AJ; Pan, XD; Zhang, BS | 1 |
| Chen, J; Farrer, M; Gwinn-Hardy, K; Hardy, J; Hussey, J; Hwu, WL; Lincoln, S; Liu, RS; Shan, DE; Sun, CM; Tai, CH; West, A; Wu, RM | 1 |
| Deuschl, G; Ghaemi, M; Heiss, WD; Hilker, R; Raethjen, J; Rudolf, J; Sobesky, J | 1 |
| Ghaemi, M; Heiss, WD; Herholz, K; Hilker, R; Sturm, V; Thiel, A; Voges, J | 1 |
| Baron, JC; Lozza, C; Marié, RM | 1 |
| Ghaemi, M; Heiss, WD; Hilker, R; Rudolf, J; Sobesky, J | 1 |
| Momose, T | 1 |
| Brooks, DJ; Pavese, N; Piccini, P | 1 |
| Remy, P | 1 |
| Cesaro, P; Cochen, V; Defer, G; Gurruchaga, JM; Hantraye, P; Loc'h, C; Nguyen, JP; Peschanski, M; Remy, P; Ribeiro, MJ; Samson, Y; Villafane, G | 1 |
| Burghaus, L; Ghaemi, M; Heiss, WD; Herholz, K; Hilker, R; Kalbe, E; Koulousakis, A; Lehrke, R; Sturm, V; Voges, J; Weisenbach, S | 1 |
| Abe, Y; Arahata, Y; Dagher, A; Hatano, K; Ito, K; Iwai, K; Kachi, T; Kato, T; Kawasumi, Y; Nagano-Saito, A; Nakamura, A; Washimi, Y; Yamada, T | 1 |
| Baron, JC; Carbon, M; Eidelberg, D; Lozza, C; Marié, RM; Mentis, MJ | 1 |
| Abe, Y; Arahata, Y; Ito, K; Iwai, K; Kachi, T; Kato, T; Kawatsu, S; Nagano-Saito, A; Nakamura, A; Washimi, Y; Yamada, T | 1 |
| Choe, B; Juh, R; Kim, J; Moon, D; Suh, T | 1 |
| Benecke, R; Dressler, D; Hilker, R; Klein, C; Pramstaller, PP; Walter, U | 1 |
| Besret, L; Bottlaender, M; Condé, F; Dauguet, J; Dollé, F; Drouot, X; Hantraye, P; Jarraya, B; Kéravel, Y; Kishima, H; Lefaucheur, JP; Oshino, S; Palfi, S; Peschanski, M; Remy, P | 1 |
| Antenor, JA; Kotagal, V; McGee-Minnich, L; Moerlein, SM; Perlmutter, JS; Racette, BA; Videen, TO | 1 |
| Ahlskog, JE; Albin, RL; Brooks, DJ; Carbon, M; Dhawan, V; Eidelberg, D; Fahn, S; Feigin, A; Guttman, M; Gwinn-Hardy, K; Holloway, R; Innis, R; Katz, RG; Kieburtz, K; Kish, SJ; Lange, N; Langston, JW; Marek, K; McFarland, H; Morin, L; Moy, C; Murphy, D; Oertel, WH; Oliver, G; Palesch, Y; Powers, W; Ravina, B; Seibyl, J; Sethi, KD; Sheehy, P; Shults, CW; Stoessl, AJ | 1 |
| Asanuma, K; Bressman, SB; Carbon-Correll, M; Edwards, C; Eidelberg, D; Huang, C; Ma, Y; Moeller, JR; Raymond, D | 1 |
| de Jong, BM; de Vries, JJ; Klein, RC; Leenders, KL | 1 |
| Choe, B; Chung, Y; Juh, R; Lee, CU; Pae, CU; Suh, T; Yang, D | 1 |
| Arzberger, T; Becker, G; Berg, D; Gerlach, M; Musicco, M; Rausch, WD; Riederer, P; Ruprecht, P; Tampellini, D; Zecca, L | 1 |
| Hayashi, K; Honda, H; Kaneko, K; Kira, J; Koga, H; Kuwabara, Y; Nakagawa, M; Sasaki, M; Taniwaki, T | 1 |
| Brooks, DJ; Hajnal, JV; Hu, MT; Khan, NL; Lees, AJ; Quinn, N; Scherfler, C; Wood, NW | 1 |
| Hundemer, HP; Kaasinen, V; Leenders, KL; Maguire, RP | 1 |
| Arias, P; Cudeiro, J; del Olmo, MF; Furio, MC; Pozo, MA | 1 |
| Barnes, A; Eidelberg, D; Ma, Y; Su, P; Su, S; Trost, M; Tseng, HM; Yen, RF | 1 |
| Biersack, HJ; Bucerius, J; Gündisch, D; Joe, AY; Minnerop, M; Reinhardt, MJ; Schmaljohann, J; Wüllner, U | 1 |
| Balash, Y; Bartels, AL; de Jong, BM; Giladi, N; Leenders, KL; Maguire, RP; Pruim, J; Schaafsma, JD; Veenma, L; Youdim, MB | 1 |
| Leenders, KL; van Beilen, M | 1 |
| Asanuma, K; Dhawan, V; Edwards, C; Eidelberg, D; Feigin, A; Kaplitt, MG; Ma, Y; Mattis, P; Tang, C | 1 |
| Miller, G | 1 |
| Ishii, K; Itokawa, K; Kawai, N; Shimazu, K; Tamura, N | 1 |
| Carbon, M; Eidelberg, D; Huang, C; Mattis, P; Perrine, K; Tang, C | 1 |
| Guan, Y; Li, D; Shen, J; Sun, B; Zan, S; Zhao, Y; Zuo, C | 1 |
| Bartus, RT; Dass, B; Gasmi, M; Herzog, CD; Holden, JE; Kordower, JH; Stansell, J; Tuszynski, MH | 1 |
| Dhawan, V; Eidelberg, D; Feigin, A; Huang, C; Lesser, M; Ma, Y; Pourfar, M; Tang, C | 1 |
| Boecker, H; Ceballos-Baumann, AO; Conrad, B; Forstl, H; Haussermann, P; Volk, D | 1 |
| Baekelandt, V; Bormans, G; Casteels, C; Lauwers, E; Van Laere, K | 1 |
| An, YS; Lee, PH; Yong, SW; Yoon, JK | 1 |
| Bentho, O; Conant, S; Eldadah, BA; Goldstein, DS; Holmes, C; Imrich, R; Moak, J; Sato, T; Sharabi, Y | 1 |
| Biseul, I; Drapier, D; Drapier, S; Fournier, S; Garin, E; Haegelen, C; Herry, JY; Le Jeune, F; Malbert, CH; Millet, B; Péron, J; Sauleau, P; Vérin, M | 1 |
| Kuhl, DE; Markham, CH; Metter, EJ; Riege, WH | 1 |
| Agid, Y; Baron, JC; Bustany, P; Collard, P; Comar, D; Rougemont, D | 1 |
| Kuhl, DE; Metter, EJ; Riege, WH | 2 |
| Antonini, A; Günther, I; Leenders, KL; Maguire, PR; Missimer, J; Psylla, M; Vontobel, P | 1 |
| Belakhlef, A; Chaly, T; Dhawan, V; Eidelberg, D; Fahn, S; Ishikawa, T; Mandel, F; Moeller, JR; Przedborski, S; Spetsieris, P | 1 |
| Bressi, S; Caraceni, T; Cortelli, P; Fazio, F; Gentrini, S; Grassi, F; Perani, D; Savoiardo, M; Testa, D | 1 |
| Chaly, T; Dahl, JR; Dhawan, V; Eidelberg, D; Ishikawa, T; Margouleff, D; Moeller, JR; Robeson, W; Spetsieris, P | 1 |
| Chaly, T; Dhawan, V; Eidelberg, D; Fahn, S; Giladi, N; Ishikawa, T; Przedborski, S; Spetsieris, P; Takikawa, S | 1 |
| Dhawan, V; Eidelberg, D; Fahn, S; Giladi, N; Goldman, S; Hildebrand, J; Przedborski, S; Takikawa, S | 1 |
| Chaly, T; Dahl, JR; Dhawan, V; Eidelberg, D; Fazzini, E; Margouleff, D; Moeller, JR; Redington, K; Robeson, W; Takikawa, S | 1 |
| Beric, A; Dhawan, V; Dogali, M; Eidelberg, D; Fazzini, E; Ishikawa, T; Moeller, JR; Silbersweig, D; Spetsieris, P; Stern, E; Woods, RP | 1 |
| Alexander, GE; Dhawan, V; Eidelberg, D; Grady, C; Ishikawa, T; Mandel, F; Moeller, JR; Pietrini, P; Spetsieris, P | 1 |
| Hirato, M; Horikoshi, S; Ishihara, J; Ohye, C; Shibazaki, T | 1 |
| Albin, RL; D'Amato, CJ; Frey, KA; Kuhl, DA; Minoshima, S; Sima, AA | 1 |
| Antonini, A; Boecker, H; Conrad, B; Grafin von Einsiedel, H; Kruggel, F; Kuwert, T; Leenders, K; Weindl, A | 1 |
| Akiguchi, I; Fukuyama, H; Hanakawa, T; Kato, M; Kimura, J; Shibasaki, H | 1 |
| Giordani, B; Koeppe, RA; Kuhl, DE; Minoshima, S; Piert, M | 1 |
| Brooks, DJ; Morrish, PK; Sawle, GV | 1 |
| Shibasaki, T | 1 |
| Arahata, Y; Kato, T; Sobue, G; Tadokoro, M | 1 |
| Bönner, H; Ghaemi, M; Heiss, WD; Herholz, K; Holthoff-Detto, VA; Kessler, J; Pietrzyk, U; Wagner, R; Wienhard, K; Würker, M | 1 |
| Albin, RL; Berent, S; Foster, NL; Frey, KA; Giordani, B; Koeppe, RA; Kuhl, DE; Minoshima, S; Vander Borght, T | 1 |
| Fukumura, T; Hosokawa, S; Ichiya, Y; Kato, M; Kuwabara, Y; Masuda, K; Otsuka, M; Sasaki, M; Yoshida, T | 1 |
| Alterman, RL; Antonini, A; Beric, A; Dhawan, V; Eidelberg, D; Fazzini, E; Kazumata, K; Kelly, P; Moeller, JR; Sterio, D | 1 |
| Antonini, A; Günther, I; Leenders, KL; Maguire, RP; Missimer, J; Psylla, M; Vontobel, P | 1 |
| Eidelberg, D; Moeller, JR | 1 |
| Antonini, A; Dhawan, V; Eidelberg, D; Feigin, A; Kazumata, K; Mandel, F; Margouleff, C | 1 |
| Damhaut, P; Dethy, S; Goldman, S; Hildebrand, J; Van Blercom, N; Wikler, D | 1 |
| Bohnen, NI; Frey, KA; Giordani, B; Kuhl, DE; Minoshima, S | 1 |
| Arahata, Y; Hirayama, M; Ieda, T; Ikeda, M; Ito, K; Kato, T; Koike, Y; Sobue, G; Tadokoro, M | 1 |
| Otsuka, M; Taniwaki, T | 1 |
| Keel, A; Leenders, KL; Ludin, HP; Nienhusmeier, M; Vonesch, T; Vontobel, P; Weder, BJ; Zaunbauer, W | 1 |
| Bergman, J; Haaparanta, M; Rinne, JO; Ruottinen, H; Solin, O; Sonninen, P | 1 |
| Bell, JD; Brooks, DJ; Chaudhuri, KR; Cunningham, VJ; Hammers, A; Hu, MT; Koepp, MJ; Labbé, C; Morris, RG; Taylor-Robinson, SD; Turjanski, N | 1 |
| Degueldre, C; Franck, G; Garraux, G; Laureys, S; Lemaire, C; Peigneux, P; Salmon, E | 1 |
| de Jong, BM; Haaxma, R; Henselmans, JM; Pruim, J; Rutgers, AW; Staal, MJ | 1 |
| Calne, DB; de la Fuente-Fernández, R; Kishore, A; Ruth, TJ; Stoessl, AJ | 1 |
| Ayman, M; Carlson, J; Fallon, J; Iacono, R; Keator, D; Lee, A; Lin, SD; Najafi, A; Salmon, E; Wu, JC | 1 |
| Bamborschke, S; Ghaemi, M; Heiss, WD; Rudolf, J; Schmülling, S | 1 |
| Hellwig, B; Juengling, FD; Kassubek, J; Knauff, M; Lücking, CH; Spreer, J | 1 |
| Antonini, A; Dhawan, V; Eidelberg, D; Fukuda, M; Hammerstad, J; Koller, WC; Lang, AE; Lozano, AM; Lyons, K; Ma, Y; Mentis, MJ; Moeller, JR | 1 |
| Jankovic, J; Kapadia, AS | 1 |
| Eidelberg, D; Fukuda, M; Liu, HM; Ma, Y; Mentis, MJ; Moeller, JR; Su, PC; Tseng, HM; Yen, RF | 1 |
| Dhawan, V; Eidelberg, D; Feigin, A; Fukuda, M; Jackson-Lewis, V; Mentis, MJ; Moeller, JR; Przedborski, S | 1 |
| Berding, G; Brooks, DJ; Dengler, R; Fricke, H; Knapp, WH; Kolbe, H; Matthies, C; Nikkhah, G; Odin, P; Peschel, T; Samii, M; Shing, M; van Den Hoff, J | 1 |
| Borbély, K | 1 |
| Goethals, I; Goldman, S; Laloux, P; Maes, A; Salmon, E; Vander Borght, T | 1 |
| Berlin, B; Dhawan, V; Edwards, C; Eidelberg, D; Feigin, A; Mattis, P; McIntosh, AR; Mentis, MJ; Perrine, K | 1 |
| Fukumura, T; Goto, I; Hosokawa, S; Ichiya, Y; Kato, M; Kuwabara, Y; Masuda, K; Otsuka, M; Sasaki, M | 1 |
| Ito, K; Kato, T; Kume, A; Sakuma, S; Shiratori, M; Tadokoro, M; Takahashi, A | 1 |
| Heiss, WD; Herholz, K; Holthoff, V; Huber, M; Karbe, H; Wagner, R; Wienhard, K | 1 |
| Snow, BJ | 1 |
| Moeller, JR; Strother, SC | 1 |
| Cedarbaum, J; Dhawan, V; Eidelberg, D; Fahn, S; Ginos, JZ; Greene, P; Moeller, JR; Rottenberg, DA; Sidtis, JJ; Strother, SC | 1 |
| Kato, M | 1 |
| Calne, DB; Okada, J; Peppard, R | 1 |
| Alavi, A; Alavi, J; Chawluk, J; Dann, R; Kushner, M; Reivich, M | 1 |
| Adam, MJ; Ammann, W; Bergstrom, M; Harrop, R; Laihinen, A; Martin, WR; Rogers, JG; Ruth, TJ; Sayre, CI; Stoessl, AJ | 1 |
| Kuhl, DE; Markham, CH; Mazziotta, JC; Metter, EJ; Phelps, ME; Riege, WH | 1 |
22 review(s) available for fluorodeoxyglucose f18 and Parkinson Disease
| Article | Year |
|---|---|
Circuit imaging biomarkers in preclinical and prodromal Parkinson's disease.
Topics: Animals; Biomarkers; Brain; Cerebrovascular Circulation; Diagnostic Imaging; Disease Management; Disease Susceptibility; Dopamine; Energy Metabolism; Fluorodeoxyglucose F18; Gene Expression Regulation; Genetic Predisposition to Disease; Humans; Magnetic Resonance Imaging; Multimodal Imaging; Neurotransmitter Agents; Parkinson Disease; Positron-Emission Tomography; Prodromal Symptoms; Severity of Illness Index | 2021 |
Metabolic imaging and plasticity.
Topics: Brain; Fluorodeoxyglucose F18; Humans; Neurodegenerative Diseases; Parkinson Disease; Parkinsonian Disorders; Positron-Emission Tomography | 2022 |
Nuclear imaging in Parkinson's disease: The past, the present, and the future.
Topics: Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neuroimaging; Parkinson Disease; Positron-Emission Tomography | 2022 |
Clinical utility of FDG PET in Parkinson's disease and atypical parkinsonism associated with dementia.
Topics: Dementia; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Parkinson Disease; Parkinsonian Disorders; Positron-Emission Tomography | 2018 |
Recent Advancement and Clinical Implications of 18FDG-PET in Parkinson's Disease, Atypical Parkinsonisms, and Other Movement Disorders.
Topics: Apathy; Brain; Cognitive Dysfunction; Dementia; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Huntington Disease; Male; Movement Disorders; Parkinson Disease; Parkinsonian Disorders; Positron-Emission Tomography; REM Sleep Behavior Disorder; Tomography, Emission-Computed, Single-Photon | 2019 |
Dyskinesias in Parkinson's disease: views from positron emission tomography studies.
Topics: Antiparkinson Agents; Dyskinesia, Drug-Induced; Fluorodeoxyglucose F18; Humans; Levodopa; Parkinson Disease; Positron-Emission Tomography | 2014 |
Functional imaging in pre-motor Parkinson's disease.
Topics: Cerebral Cortex; Dopamine; Fluorodeoxyglucose F18; Humans; Parkinson Disease; Positron-Emission Tomography; REM Sleep Behavior Disorder; Reproducibility of Results; Risk; Tomography, Emission-Computed, Single-Photon | 2014 |
Molecular imaging in genetics.
Topics: Alzheimer Disease; Brain; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Molecular Imaging; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals | 2015 |
Metabolic Imaging in Parkinson Disease.
Topics: Biomarkers; Brain; Brain Mapping; Cognitive Dysfunction; Fluorodeoxyglucose F18; Glucose; Humans; Image Interpretation, Computer-Assisted; Molecular Imaging; Parkinson Disease; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2017 |
[Functional imaging of deep brain stimulation in idiopathic Parkinson's disease].
Topics: Affect; Basal Ganglia; Brain; Brain Mapping; Cognition; Deep Brain Stimulation; Dopamine; Fluorodeoxyglucose F18; Frontal Lobe; Humans; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Limbic System; Nerve Net; Neurons; Neuropsychological Tests; Parkinson Disease; Positron-Emission Tomography; Subthalamic Nucleus; Verbal Behavior | 2010 |
[Nuclear medicine imaging in patients with Parkinson's syndrome: an update].
Topics: Animals; Brain; Dihydroxyphenylalanine; Disease Progression; Dopamine; Energy Metabolism; Fluorodeoxyglucose F18; Genetic Predisposition to Disease; Humans; Nerve Degeneration; Neurons; Parkinson Disease; Parkinsonian Disorders; Positron-Emission Tomography; Receptors, Dopamine; Regional Blood Flow; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon | 2010 |
Radionuclide brain imaging correlates of cognitive impairment in Parkinson's disease (PD).
Topics: Aniline Compounds; Benzothiazoles; Brain; Brain Mapping; Cognition Disorders; Fluorodeoxyglucose F18; Humans; Parkinson Disease; Positron-Emission Tomography; Thiazoles; Tomography, Emission-Computed, Single-Photon | 2011 |
New developments of dopaminergic imaging in Parkinson's disease.
Topics: Biomarkers; Brain; Dopamine Plasma Membrane Transport Proteins; Fluorodeoxyglucose F18; Humans; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; Serotonin Plasma Membrane Transport Proteins; Tomography, Emission-Computed, Single-Photon | 2012 |
Functional neuroimaging in Parkinson's disease.
Topics: Antiparkinson Agents; Brain Diseases, Metabolic; Cognition Disorders; Disease Progression; Dopamine; Dyskinesia, Drug-Induced; Fluorodeoxyglucose F18; Functional Neuroimaging; Humans; Levodopa; Lewy Bodies; Magnetic Resonance Imaging; Neurotransmitter Agents; Parkinson Disease; Positron-Emission Tomography; Psychomotor Disorders; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon | 2012 |
[Is functional imaging useful in the clinical evaluation of Parkinson's disease?].
Topics: Brain; Corpus Striatum; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Parkinson Disease; Radiopharmaceuticals; Receptors, Dopamine D2; Receptors, Presynaptic; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2003 |
The role of radiotracer imaging in Parkinson disease.
Topics: Biomarkers; Biotransformation; Blood-Brain Barrier; Carbon Radioisotopes; Clinical Trials as Topic; Cocaine; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Forecasting; Humans; Iodine Radioisotopes; Neurons; Parkinson Disease; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Receptors, Dopamine; Substantia Nigra; Tetrabenazine; Tomography, Emission-Computed, Single-Photon | 2005 |
[Glucose metabolism and blood flow studies in 2 cases with juvenile Parkinson's disease].
Topics: Adult; Age of Onset; Brain; Cerebrovascular Circulation; Deoxyglucose; Female; Fingers; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Movement; Parkinson Disease; Rest; Tomography, Emission-Computed | 1997 |
[18F-fluorodeoxyglucose positron emission tomography in Parkinson's disease].
Topics: Brain; Deoxyglucose; Diagnosis, Differential; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Parkinson Disease; Tomography, Emission-Computed | 1997 |
[Functional imaging for disorders of basal ganglia].
Topics: Basal Ganglia; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Huntington Disease; Multiple System Atrophy; Parkinson Disease; Radiopharmaceuticals; Supranuclear Palsy, Progressive; Tomography, Emission-Computed | 1999 |
[Functional neuroimaging in movement disorders].
Topics: Brain; Carbon Radioisotopes; Cerebrovascular Circulation; Dopamine; Dopamine Plasma Membrane Transport Proteins; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Membrane Glycoproteins; Membrane Transport Proteins; Movement Disorders; Nerve Tissue Proteins; Parkinson Disease; Radiopharmaceuticals; Receptors, Dopamine; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2001 |
Positron emission tomography in Parkinson's disease.
Topics: Deoxyglucose; Dopamine; Fluorodeoxyglucose F18; Humans; Parkinson Disease; Tomography, Emission-Computed | 1992 |
Positron emission tomography imaging of regional cerebral glucose metabolism.
Topics: Aging; Brain; Brain Diseases; Brain Neoplasms; Central Nervous System Diseases; Cerebrovascular Disorders; Dementia; Deoxyglucose; Epilepsy; Fluorodeoxyglucose F18; Glucose; Humans; Huntington Disease; Parkinson Disease; Radiography; Schizophrenia; Tissue Distribution; Tomography, Emission-Computed | 1986 |
14 trial(s) available for fluorodeoxyglucose f18 and Parkinson Disease
| Article | Year |
|---|---|
Correlations between dopaminergic dysfunction and abnormal metabolic network activity in REM sleep behavior disorder.
Topics: Aged; Corpus Striatum; Dopamine; Dopamine Plasma Membrane Transport Proteins; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography; REM Sleep Behavior Disorder; Tropanes | 2020 |
Pre-frontal-insular-cerebellar modifications correlate with disgust feeling blunting after subthalamic stimulation: A positron emission tomography study in Parkinson's disease.
Topics: Cerebellum; Cerebral Cortex; Deep Brain Stimulation; Emotions; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Positron-Emission Tomography; Prefrontal Cortex; Subthalamic Nucleus | 2017 |
STN-DBS activates the target area in Parkinson disease: an FDG-PET study.
Topics: Aged; Deep Brain Stimulation; Electrodes; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Severity of Illness Index; Subthalamic Nucleus; Time Factors; Treatment Outcome | 2008 |
Changes in cerebral glucose metabolism in patients with Parkinson disease with dementia after cholinesterase inhibitor therapy.
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Brain; Cholinesterase Inhibitors; Dementia; Female; Fluorodeoxyglucose F18; Humans; Male; Parkinson Disease; Radionuclide Imaging; Radiopharmaceuticals; Tissue Distribution; Treatment Outcome | 2008 |
Frontal FDG-PET activity correlates with cognitive outcome after STN-DBS in Parkinson disease.
Topics: Aged; Chi-Square Distribution; Cognition; Confidence Intervals; Deep Brain Stimulation; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Frontal Lobe; Humans; Linear Models; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Odds Ratio; Parkinson Disease; Positron-Emission Tomography; Subthalamic Nucleus | 2009 |
Subthalamic nucleus stimulation in Parkinson disease induces apathy: a PET study.
Topics: Aged; Brain Mapping; Deep Brain Stimulation; Depression; Female; Fluorodeoxyglucose F18; Humans; Male; Mental Status Schedule; Middle Aged; Neuropsychological Tests; Parkinson Disease; Positron-Emission Tomography; Statistics as Topic; Subthalamic Nucleus; Time Factors | 2009 |
Subthalamic nucleus stimulation affects limbic and associative circuits: a PET study.
Topics: Case-Control Studies; Deep Brain Stimulation; Female; Fluorodeoxyglucose F18; Glucose; Humans; Limbic System; Male; Middle Aged; Motor Activity; Nerve Net; Neuropsychological Tests; Parkinson Disease; Positron-Emission Tomography; Prefrontal Cortex; Subthalamic Nucleus | 2010 |
Attentional set-shifting deficit in Parkinson's disease is associated with prefrontal dysfunction: an FDG-PET study.
Topics: Aged; Analysis of Variance; Attention; Brain Mapping; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Parkinson Disease; Pattern Recognition, Visual; Prefrontal Cortex; Psychomotor Performance; Regression Analysis; Set, Psychology; Tomography, Emission-Computed | 2012 |
The influence of residual nor-β-CFT in 11C CFT injection on the Parkinson disease diagnosis: a 11C CFT PET study.
Topics: Carbon Radioisotopes; Cocaine; Drug Residues; Female; Fluorodeoxyglucose F18; Humans; Injections, Intravenous; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography | 2012 |
The metabolic substrates of bradykinesia and tremor in uncomplicated Parkinson's disease.
Topics: Aged; Brain Chemistry; Female; Fluorodeoxyglucose F18; Glucose; Humans; Hypokinesia; Image Interpretation, Computer-Assisted; Kinetics; Male; Middle Aged; Parkinson Disease; Radiopharmaceuticals; Tomography, Emission-Computed; Tremor | 2002 |
Subthalamic nucleus stimulation restores glucose metabolism in associative and limbic cortices and in cerebellum: evidence from a FDG-PET study in advanced Parkinson's disease.
Topics: Aged; Brain Chemistry; Cerebellar Cortex; Electric Stimulation; Electrodes, Implanted; Female; Fluorodeoxyglucose F18; Glucose; Humans; Kinetics; Limbic System; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Radiopharmaceuticals; Radiosurgery; Subthalamic Nucleus; Tomography, Emission-Computed; Treatment Outcome | 2004 |
PET evaluation of the relationship between D2 receptor binding and glucose metabolism in patients with parkinsonism.
Topics: Adult; Aged; Antiparkinson Agents; Brain; Female; Fluorodeoxyglucose F18; Glucose; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Raclopride; Radiopharmaceuticals; Receptors, Dopamine D2; Tissue Distribution | 2005 |
Evaluation of the effect of training using auditory stimulation on rhythmic movement in Parkinsonian patients--a combined motor and [18F]-FDG PET study.
Topics: Acoustic Stimulation; Aged; Auditory Cortex; Female; Fingers; Fluorodeoxyglucose F18; Gait; Humans; Male; Middle Aged; Motor Cortex; Movement; Parkinson Disease; Patient Education as Topic; Physical Therapy Modalities; Program Evaluation; Radionuclide Imaging; Time Perception | 2006 |
Network modulation in the treatment of Parkinson's disease.
Topics: Adult; Aged; Analysis of Variance; Antiparkinson Agents; Cerebellum; Deep Brain Stimulation; Female; Fluorodeoxyglucose F18; Globus Pallidus; Glucose; Humans; Levodopa; Linear Models; Male; Middle Aged; Motor Cortex; Neuropsychological Tests; Parkinson Disease; Positron-Emission Tomography; Putamen; Subthalamic Nucleus; Treatment Outcome | 2006 |
258 other study(ies) available for fluorodeoxyglucose f18 and Parkinson Disease
| Article | Year |
|---|---|
Heterogeneity by global and textural feature analysis in F-18 FP-CIT brain PET images for diagnosis of Parkinson's disease.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neuroimaging; Parkinson Disease; Positron-Emission Tomography; Retrospective Studies | 2021 |
Neural correlates and predictors of subjective cognitive decline in patients with Parkinson's disease.
Topics: Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Humans; Male; Neuropsychological Tests; Parkinson Disease; Positron-Emission Tomography; Retrospective Studies | 2022 |
Metabolic correlates of olfactory dysfunction in COVID-19 and Parkinson's disease (PD) do not overlap.
Topics: Anosmia; COVID-19; Fluorodeoxyglucose F18; Humans; Olfaction Disorders; Parkinson Disease; RNA, Viral; SARS-CoV-2; Smell | 2022 |
Multimodal imaging of a patient with RAB39B mutation.
Topics: Adult; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Mutation; Parkinson Disease; Positron-Emission Tomography; rab GTP-Binding Proteins | 2022 |
Brain Metabolism Related to Mild Cognitive Impairment and Phenoconversion in Patients With Isolated REM Sleep Behavior Disorder.
Topics: Brain; Cognitive Dysfunction; Fluorodeoxyglucose F18; Humans; Parkinson Disease; Prospective Studies; REM Sleep Behavior Disorder | 2022 |
Abnormal metabolic covariance patterns associated with multiple system atrophy and progressive supranuclear palsy.
Topics: Fluorodeoxyglucose F18; Humans; Multiple System Atrophy; Parkinson Disease; Parkinsonian Disorders; Supranuclear Palsy, Progressive | 2022 |
Use of deep learning-based radiomics to differentiate Parkinson's disease patients from normal controls: a study based on [
Topics: Deep Learning; Fluorodeoxyglucose F18; Humans; Parkinson Disease; Positron-Emission Tomography; Prospective Studies | 2022 |
Tau-PET and multimodal imaging in clinically atypical multiple system atrophy masquerading as progressive supranuclear palsy.
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Levodopa; Magnetic Resonance Imaging; Multimodal Imaging; Multiple System Atrophy; Parkinson Disease; Parkinsonian Disorders; Supranuclear Palsy, Progressive | 2022 |
Topics: Fluorodeoxyglucose F18; Humans; Multiple System Atrophy; Parkinson Disease; Positron-Emission Tomography; Putamen; Tomography, X-Ray Computed | 2022 |
FDG-PET combined with learning vector quantization allows classification of neurodegenerative diseases and reveals the trajectory of idiopathic REM sleep behavior disorder.
Topics: Fluorodeoxyglucose F18; Humans; Neurodegenerative Diseases; Parkinson Disease; Positron-Emission Tomography; REM Sleep Behavior Disorder | 2022 |
Predicting cognitive decline in Parkinson's disease using FDG-PET-based supervised learning.
Topics: Cognitive Dysfunction; Dementia; Fluorodeoxyglucose F18; Humans; Parkinson Disease; Retrospective Studies; Supervised Machine Learning | 2022 |
Stereotyped Relationship Between Motor and Cognitive Metabolic Networks in Parkinson's Disease.
Topics: Brain; Cognition; Fluorodeoxyglucose F18; Humans; Metabolic Networks and Pathways; Parkinson Disease; Positron-Emission Tomography; REM Sleep Behavior Disorder | 2022 |
Derivation and Validation of a Phenoconversion-Related Pattern in Idiopathic Rapid Eye Movement Behavior Disorder.
Topics: Biomarkers; Female; Fluorodeoxyglucose F18; Glucose; Humans; Parkinson Disease; REM Sleep Behavior Disorder; Sleep, REM | 2023 |
Structural and metabolic correlates of neuropsychological profiles in multiple system atrophy and Parkinson's disease.
Topics: Diffusion Tensor Imaging; Fluorodeoxyglucose F18; Humans; Multiple System Atrophy; Neuropsychological Tests; Parkinson Disease; Parkinsonian Disorders | 2023 |
Disassociation between fluctuation shift over frequency and glucose metabolism in motor cortex of Parkinson's disease: a hybrid PET/fMRI study.
Topics: Fluorodeoxyglucose F18; Glucose; Humans; Magnetic Resonance Imaging; Motor Cortex; Parkinson Disease; Positron-Emission Tomography; Rest | 2023 |
Right posterior hypometabolism in Pisa syndrome of Parkinson's disease: A key to explain body schema perception deficit?
Topics: Body Image; Dopamine Plasma Membrane Transport Proteins; Fluorodeoxyglucose F18; Humans; Parkinson Disease; Positron-Emission Tomography; Retrospective Studies | 2023 |
Impaired self-awareness of cognitive deficits in Parkinson's disease relates to cingulate cortex dysfunction.
Topics: Brain; Cognition; Cognitive Dysfunction; Fluorodeoxyglucose F18; Glucose; Gyrus Cinguli; Humans; Magnetic Resonance Imaging; Parkinson Disease; Tomography, X-Ray Computed | 2023 |
Activated Microglia in the Early Stage of a Rat Model of Parkinson's Disease: Revealed by PET-MRI Imaging by [
Topics: Animals; Carrier Proteins; Disease Models, Animal; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Magnetic Resonance Imaging; Microglia; Oxidopamine; Parkinson Disease; Positron-Emission Tomography; Rats | 2023 |
Occipital hypometabolism is a risk factor for conversion to Parkinson's disease in isolated REM sleep behaviour disorder.
Topics: 3-Iodobenzylguanidine; Fluorodeoxyglucose F18; Humans; Parkinson Disease; Positron-Emission Tomography; REM Sleep Behavior Disorder; Risk Factors | 2023 |
Comparison of univariate and multivariate analyses for brain [18F]FDG PET data in α-synucleinopathies.
Topics: Alzheimer Disease; Brain; Fluorodeoxyglucose F18; Humans; Lewy Body Disease; Multiple System Atrophy; Multivariate Analysis; Parkinson Disease; Positron-Emission Tomography; Synucleinopathies | 2023 |
Multimodal imaging study of the 5-HT
Topics: Animals; Dyskinesias; Fluorodeoxyglucose F18; Levodopa; Multimodal Imaging; Parkinson Disease; Rats; Receptor, Serotonin, 5-HT1A; Serotonin | 2023 |
Metabolic Brain Changes Can Predict the Underlying Pathology in Neurodegenerative Brain Disorders: A Case Report of Sporadic Creutzfeldt-Jakob Disease with Concomitant Parkinson's Disease.
Topics: Aged; Brain; Creutzfeldt-Jakob Syndrome; Fluorodeoxyglucose F18; Humans; Neurodegenerative Diseases; Parkinson Disease | 2023 |
Identifying a glucose metabolic brain pattern in an adeno-associated viral vector based rat model for Parkinson's disease using
Topics: Animals; Brain; Dependovirus; Disease Models, Animal; Female; Fluorodeoxyglucose F18; Genetic Vectors; Glucose; Motor Activity; Parkinson Disease; Positron-Emission Tomography; Rats, Wistar; Support Vector Machine | 2019 |
Association of striatal dopaminergic neuronal integrity with cognitive dysfunction and cerebral cortical metabolism in Parkinson's disease with mild cognitive impairment.
Topics: Cerebral Cortex; Cognitive Dysfunction; Dopamine; Dopamine Plasma Membrane Transport Proteins; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neostriatum; Neurons; Parkinson Disease; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2019 |
Functional impact of subthalamotomy by magnetic resonance-guided focused ultrasound in Parkinson's disease: a hybrid PET/MR study of resting-state brain metabolism.
Topics: Brain; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Parkinson Disease | 2020 |
Cognitive signature of brain FDG PET based on deep learning: domain transfer from Alzheimer's disease to Parkinson's disease.
Topics: Alzheimer Disease; Brain; Cognition; Cognitive Dysfunction; Deep Learning; Fluorodeoxyglucose F18; Humans; Parkinson Disease; Positron-Emission Tomography | 2020 |
Abnormal pattern of brain glucose metabolism in Parkinson's disease: replication in three European cohorts.
Topics: Brain; Fluorodeoxyglucose F18; Glucose; Humans; Italy; Netherlands; Parkinson Disease; Positron-Emission Tomography; Spain | 2020 |
Combined 18F-fluorodeoxyglucose positron emission tomography and event-related potentials study of the cognitive impairment mechanisms in Parkinson's disease.
Topics: Aged; Cognitive Dysfunction; Evoked Potentials; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Temporal Lobe | 2020 |
Preservation of brain metabolism in recently diagnosed Parkinson's impulse control disorders.
Topics: Brain; Case-Control Studies; Disruptive, Impulse Control, and Conduct Disorders; Fluorodeoxyglucose F18; Humans; Parkinson Disease | 2020 |
Network degeneration in Parkinson's disease: multimodal imaging of nigro-striato-cortical dysfunction.
Topics: Aged; Case-Control Studies; Cerebral Cortex; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Female; Fluorodeoxyglucose F18; Functional Neuroimaging; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neural Pathways; Parkinson Disease; Positron-Emission Tomography; Putamen; Substantia Nigra | 2020 |
Brain metabolic alterations herald falls in patients with Parkinson's disease.
Topics: Accidental Falls; Aged; Cerebellum; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glucose; Humans; Male; Middle Aged; Parietal Lobe; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals | 2020 |
In-vivo signatures of neurodegeneration in isolated rapid eye movement sleep behaviour disorder.
Topics: Brain; Fluorodeoxyglucose F18; Humans; Parkinson Disease; Positron-Emission Tomography; REM Sleep Behavior Disorder | 2020 |
Atypical clinical presentation of pathologically proven Parkinson's disease: The role of Parkinson's disease related metabolic pattern.
Topics: Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography | 2020 |
Hemispheric Network Expression in Parkinson's Disease: Relationship to Dopaminergic Asymmetries.
Topics: Aged; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Dopamine Agents; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nerve Net; Parkinson Disease; Positron-Emission Tomography | 2020 |
Characterization of idiopathic Parkinson's disease subgroups using quantitative gait analysis and corresponding subregional striatal uptake visualized using
Topics: Aged; Corpus Striatum; Female; Fluorodeoxyglucose F18; Gait Analysis; Humans; Male; Parkinson Disease; Positron-Emission Tomography; Retrospective Studies | 2020 |
Clinical features, MRI, and 18F-FDG-PET in differential diagnosis of Parkinson disease from multiple system atrophy.
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Multiple System Atrophy; Parkinson Disease | 2020 |
An application of generalized matrix learning vector quantization in neuroimaging.
Topics: Europe; Fluorodeoxyglucose F18; Humans; Neuroimaging; Parkinson Disease; Positron-Emission Tomography; Principal Component Analysis | 2020 |
Spectral guided sparse inverse covariance estimation of metabolic networks in Parkinson's disease.
Topics: Adult; Aged; Brain; Case-Control Studies; Female; Fluorodeoxyglucose F18; Functional Neuroimaging; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Neural Pathways; Parkinson Disease; Positron-Emission Tomography; Principal Component Analysis; Radiopharmaceuticals | 2021 |
Efficacy of 11C-2β-carbomethoxy-3β-(4-fluorophenyl) tropane positron emission tomography combined with 18F-fluorodeoxyglucose positron emission tomography in the diagnosis of early Parkinson disease: A protocol for systematic review and meta analysis.
Topics: Fluorodeoxyglucose F18; Humans; Meta-Analysis as Topic; Multimodal Imaging; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; Randomized Controlled Trials as Topic; Research Design; Sensitivity and Specificity; Severity of Illness Index; Systematic Review as Topic; Tropanes | 2020 |
Functional Role of the Cerebellum in Parkinson Disease: A PET Study.
Topics: Adult; Aged; Basal Ganglia; Behavioral Symptoms; Cerebellum; Cerebral Cortex; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nerve Net; Parkinson Disease; Positron-Emission Tomography; Principal Component Analysis; Thalamus | 2021 |
123I-Ioflupane SPECT and 18F-FDG PET Combined Use in the Characterization of Movement and Cognitive Associated Disorders in Neurodegenerative Diseases.
Topics: Alzheimer Disease; Brain; Cognition Disorders; Fluorodeoxyglucose F18; Humans; Movement Disorders; Neurodegenerative Diseases; Nortropanes; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed, Single-Photon | 2021 |
Cerebral glucose metabolism and cognition in newly diagnosed Parkinson's disease: ICICLE-PD study.
Topics: Aged; Aged, 80 and over; Blood Glucose; Brain; Brain Mapping; Cognitive Dysfunction; Cohort Studies; England; Female; Fluorodeoxyglucose F18; Humans; Longitudinal Studies; Male; Mental Status Schedule; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Statistics as Topic | 2017 |
The utility of FDG-PET in the differential diagnosis of Parkinsonism.
Topics: Adult; Aged; Aged, 80 and over; Brain; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multiple System Atrophy; Parkinson Disease; Parkinsonian Disorders; Positron-Emission Tomography; Radiopharmaceuticals; Supranuclear Palsy, Progressive | 2017 |
Abnormal metabolic brain network associated with Parkinson's disease: replication on a new European sample.
Topics: Aged; Brain; Case-Control Studies; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2017 |
Cerebral metabolic change in Parkinson's disease patients with anxiety: A FDG-PET study.
Topics: Aged; Anxiety; Cerebral Cortex; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Neural Pathways; Parkinson Disease; Positron-Emission Tomography | 2017 |
Altered brain metabolic connectivity at multiscale level in early Parkinson's disease.
Topics: Aged; Basal Ganglia; Cerebellum; Connectome; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Nerve Net; Neural Pathways; Parkinson Disease; Positron-Emission Tomography | 2017 |
FDG PET, dopamine transporter SPECT, and olfaction: Combining biomarkers in REM sleep behavior disorder.
Topics: Aged; Analysis of Variance; Cross-Sectional Studies; Dopamine Plasma Membrane Transport Proteins; Female; Fluorodeoxyglucose F18; Humans; Lewy Body Disease; Male; Middle Aged; Olfaction Disorders; Parkinson Disease; Positron-Emission Tomography; Psychiatric Status Rating Scales; REM Sleep Behavior Disorder; Tomography, Emission-Computed, Single-Photon | 2017 |
Brain metabolic correlates of fatigue in Parkinson's disease: a PET study.
Topics: Aged; Aged, 80 and over; Cerebral Cortex; Fatigue; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Psychiatric Status Rating Scales; Severity of Illness Index; Statistics as Topic | 2018 |
Topics: Brain; Brain Mapping; Dihydroxyphenylalanine; Disease Progression; Dopamine Agents; Female; Fluorodeoxyglucose F18; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Male; Middle Aged; Nortropanes; Parkinson Disease; Positron-Emission Tomography; Severity of Illness Index | 2018 |
Cognitive profile and 18F-fluorodeoxyglucose PET study in LRRK2-related Parkinson's disease.
Topics: Adult; Aged; Cognition Disorders; Female; Fluorodeoxyglucose F18; Humans; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Male; Middle Aged; Neuropsychological Tests; Parietal Lobe; Parkinson Disease; Positron-Emission Tomography | 2018 |
Overlapping and distinct neural metabolic patterns related to impulsivity and hypomania in Parkinson's disease.
Topics: Adolescent; Adult; Aged; Brain; Female; Fluorodeoxyglucose F18; Humans; Impulsive Behavior; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; Rest; Young Adult | 2019 |
Single-subject SPM FDG-PET patterns predict risk of dementia progression in Parkinson disease.
Topics: Aged; Brain; Dementia; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Models, Statistical; Parkinson Disease; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Risk Assessment; Sensitivity and Specificity | 2018 |
Reproducible network and regional topographies of abnormal glucose metabolism associated with progressive supranuclear palsy: Multivariate and univariate analyses in American and Chinese patient cohorts.
Topics: Aged; Brain; Brain Mapping; China; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Multiple System Atrophy; Nerve Net; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; Supranuclear Palsy, Progressive; United States | 2018 |
[
Topics: Aged; Aged, 80 and over; Benzamides; Brain Mapping; Corpus Striatum; Dopamine D2 Receptor Antagonists; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Parkinson Disease; Positron-Emission Tomography; Receptors, Dopamine D2 | 2018 |
Brain PET substrate of impulse control disorders in Parkinson's disease: A metabolic connectivity study.
Topics: Brain; Brain Mapping; Disruptive, Impulse Control, and Conduct Disorders; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neural Pathways; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals | 2018 |
Clinical, Dopaminergic, and Metabolic Correlations in Parkinson Disease: A Dual-Tracer PET Study.
Topics: Aged; Brain; Dopamine; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; Tropanes | 2018 |
Defining visual illusions in Parkinson's disease: Kinetopsia and object misidentification illusions.
Topics: Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Hallucinations; Humans; Illusions; Magnetic Resonance Imaging; Male; Mental Status Schedule; Middle Aged; Neuropsychological Tests; Parkinson Disease; Positron-Emission Tomography; Surveys and Questionnaires | 2018 |
Freezing of gait in Parkinson's disease: functional neuroimaging studies of the frontal lobe.
Topics: Aged; Animals; Antiparkinson Agents; Female; Fluorodeoxyglucose F18; Frontal Lobe; Functional Neuroimaging; Gait Disorders, Neurologic; Humans; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Positron-Emission Tomography | 2018 |
Clinical characteristics of cognitive impairment in patients with Parkinson's disease and its related pattern in
Topics: Adult; Aged; Aged, 80 and over; Attention; Cognitive Dysfunction; Dementia; Executive Function; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography | 2018 |
Hypermetabolism in the cerebellum and brainstem and cortical hypometabolism are independently associated with cognitive impairment in Parkinson's disease.
Topics: Aged; Brain Stem; Case-Control Studies; Cerebellum; Cerebral Cortex; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals | 2018 |
Hemispheric specialization of the basal ganglia during vocal emotion decoding: Evidence from asymmetric Parkinson's disease and
Topics: Basal Ganglia; Brain Mapping; Emotions; Female; Fluorodeoxyglucose F18; Functional Laterality; Glucose; Humans; Male; Middle Aged; Motor Activity; Parkinson Disease; Pattern Recognition, Physiological; Positron-Emission Tomography; Radiopharmaceuticals; Recognition, Psychology; Rest; Speech Perception | 2018 |
The effects of image reconstruction algorithms on topographic characteristics, diagnostic performance and clinical correlation of metabolic brain networks in Parkinson's disease.
Topics: Algorithms; Brain; Cohort Studies; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Neural Pathways; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2018 |
Machine learning identified an Alzheimer's disease-related FDG-PET pattern which is also expressed in Lewy body dementia and Parkinson's disease dementia.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Female; Fluorodeoxyglucose F18; Humans; Lewy Body Disease; Machine Learning; Male; Middle Aged; Neuroimaging; Parkinson Disease; Positron-Emission Tomography; Support Vector Machine | 2018 |
FDG PET Parkinson's disease-related pattern as a biomarker for clinical trials in early stage disease.
Topics: Adult; Aged; Aged, 80 and over; Clinical Trials as Topic; Cohort Studies; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multivariate Analysis; Parkinson Disease; Positron-Emission Tomography | 2018 |
[Statistical parametric mapping analysis of
Topics: Brain; Cognitive Dysfunction; Fluorodeoxyglucose F18; Humans; Parkinson Disease; Positron-Emission Tomography | 2018 |
Cerebral Metabolic Changes Related to Freezing of Gait in Parkinson Disease.
Topics: Aged; Brain; Female; Fluorodeoxyglucose F18; Gait Disorders, Neurologic; Humans; Male; Parkinson Disease; Positron-Emission Tomography; Treatment Outcome | 2019 |
Brain Glucose Metabolism Heterogeneity in Idiopathic REM Sleep Behavior Disorder and in Parkinson's Disease.
Topics: Aged; Brain; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography; REM Sleep Behavior Disorder | 2019 |
Scaled Subprofile Modeling and Convolutional Neural Networks for the Identification of Parkinson's Disease in 3D Nuclear Imaging Data.
Topics: Aged; Brain; Case-Control Studies; Female; Fluorodeoxyglucose F18; Functional Neuroimaging; Humans; Imaging, Three-Dimensional; Male; Middle Aged; Models, Statistical; Neural Networks, Computer; Parkinson Disease; Positron-Emission Tomography; Principal Component Analysis | 2019 |
Effects of subthalamic deep brain stimulation on striatal metabolic connectivity in a rat hemiparkinsonian model.
Topics: Animals; Corpus Striatum; Deep Brain Stimulation; Disease Models, Animal; Dopaminergic Neurons; Fluorodeoxyglucose F18; Male; Parkinson Disease; Rats, Long-Evans; Subthalamic Nucleus | 2019 |
Nigrostriatal dopamine transporter availability, and its metabolic and clinical correlates in Parkinson's disease patients with impulse control disorders.
Topics: Aged; Corpus Striatum; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Plasma Membrane Transport Proteins; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; Substantia Nigra; Tomography, Emission-Computed, Single-Photon | 2019 |
Putaminal Dopamine Turnover in de novo Parkinson's Disease Predicts Later Neuropsychiatric Fluctuations but Not Other Major Health Outcomes.
Topics: Aged; Caudate Nucleus; Dopamine; Female; Fluorodeoxyglucose F18; Humans; Male; Neuropsychological Tests; Parkinson Disease; Positron-Emission Tomography; Putamen; Quality of Life; Retrospective Studies | 2019 |
Neuroimaging markers of motor and nonmotor features of Parkinson's disease: an 18f fluorodeoxyglucose positron emission computed tomography study.
Topics: Aged; Biomarkers; Blood Glucose; Brain; Brain Mapping; Case-Control Studies; Female; Fluorodeoxyglucose F18; Humans; Logistic Models; Magnetic Resonance Imaging; Male; Neuropsychological Tests; Parkinson Disease; Positron-Emission Tomography; ROC Curve | 2013 |
Neuroprotective Properties of Standardized Extracts of Hypericum perforatum on Rotenone Model of Parkinson's Disease.
Topics: Analysis of Variance; Animals; Apoptosis Regulatory Proteins; Brain; Catalepsy; Corpus Striatum; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Fluorodeoxyglucose F18; Hypericum; Insecticides; Liposomes; Male; Maze Learning; Neurons; Neuroprotective Agents; Parkinson Disease; Phytotherapy; Positron-Emission Tomography; Quercetin; Rats; Rats, Wistar; Rotenone; Swimming | 2013 |
Metabolic brain network in the Chinese patients with Parkinson's disease based on 18F-FDG PET imaging.
Topics: Adult; Aged; Asian People; Brain; Brain Mapping; Case-Control Studies; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Linear Models; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography; ROC Curve; Severity of Illness Index | 2013 |
Parkinson's disease cognitive network correlates with caudate dopamine.
Topics: Caudate Nucleus; Dopamine; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; Tropanes | 2013 |
Characterization of disease-related covariance topographies with SSMPCA toolbox: effects of spatial normalization and PET scanners.
Topics: Adult; Aged; Algorithms; Area Under Curve; Brain; Brain Mapping; Fluorodeoxyglucose F18; Humans; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Principal Component Analysis; Radiopharmaceuticals; Reference Values; Software | 2014 |
Benefits of putaminal GDNF infusion in Parkinson disease are maintained after GDNF cessation.
Topics: Antiparkinson Agents; Fluorodeoxyglucose F18; Glial Cell Line-Derived Neurotrophic Factor; Humans; Male; Middle Aged; Parkinson Disease; Putamen; Severity of Illness Index; Time Factors; Tomography, Emission-Computed | 2013 |
Visual hallucinations and cognitive impairment in Parkinson's disease.
Topics: Aged; Brain; Brain Mapping; Cognition Disorders; Female; Fluorodeoxyglucose F18; Hallucinations; Humans; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Positron-Emission Tomography; Severity of Illness Index | 2013 |
Apathy and impaired emotional facial recognition networks overlap in Parkinson's disease: a PET study with conjunction analyses.
Topics: Aged; Apathy; Brain Mapping; Facial Expression; Fluorodeoxyglucose F18; Frontal Lobe; Gyrus Cinguli; Humans; Image Processing, Computer-Assisted; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Recognition, Psychology | 2014 |
Abnormal metabolic network activity in REM sleep behavior disorder.
Topics: Aged; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lewy Body Disease; Middle Aged; Multimodal Imaging; Parkinson Disease; Positron-Emission Tomography; Predictive Value of Tests; REM Sleep Behavior Disorder; Single-Blind Method; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2014 |
Predicting the development of levodopa-induced dyskinesias: a presynaptic mechanism?
Topics: Amantadine; Antiparasitic Agents; Dyskinesia, Drug-Induced; Fluorodeoxyglucose F18; Humans; Levodopa; Parkinson Disease; Positron-Emission Tomography; Presynaptic Terminals | 2014 |
Parkinson's disease subtypes show a specific link between dopaminergic and glucose metabolism in the striatum.
Topics: Aged; Dihydroxyphenylalanine; Dopamine; Dopaminergic Neurons; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Parkinson Disease; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Ventral Striatum | 2014 |
Grey matter hypometabolism and atrophy in Parkinson's disease with cognitive impairment: a two-step process.
Topics: Aged; Aged, 80 and over; Atrophy; Cerebral Cortex; Cognitive Dysfunction; Cross-Sectional Studies; Dementia; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Neuroimaging; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; Severity of Illness Index | 2014 |
Parkinson's disease-related perfusion and glucose metabolic brain patterns identified with PCASL-MRI and FDG-PET imaging.
Topics: Brain; Female; Fluorodeoxyglucose F18; Glucose; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Parkinson Disease; Radionuclide Imaging | 2014 |
Influence of microglial activation on neuronal function in Alzheimer's and Parkinson's disease dementia.
Topics: Alzheimer Disease; Amyloid; Brain; Brain Mapping; Carbon Radioisotopes; Cognitive Dysfunction; Fluorodeoxyglucose F18; Glucose; Humans; Isoquinolines; Magnetic Resonance Imaging; Microglia; Neuropsychological Tests; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; Signal Processing, Computer-Assisted | 2015 |
The utility of susceptibility-weighted imaging for differentiating Parkinsonism-predominant multiple system atrophy from Parkinson's disease: correlation with 18F-flurodeoxyglucose positron-emission tomography.
Topics: Aged; Aged, 80 and over; Diagnosis, Differential; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple System Atrophy; Parkinson Disease; Parkinsonian Disorders; Positron-Emission Tomography; Putamen; Radiopharmaceuticals; Retrospective Studies | 2015 |
Pareidolia in Parkinson's disease without dementia: A positron emission tomography study.
Topics: Aged; Dementia; Energy Metabolism; Female; Fluorodeoxyglucose F18; Functional Laterality; Hallucinations; Humans; Illusions; Male; Middle Aged; Occipital Lobe; Parietal Lobe; Parkinson Disease; Photic Stimulation; Positron-Emission Tomography; Temporal Lobe | 2015 |
Classification of Parkinsonian syndromes from FDG-PET brain data using decision trees with SSM/PCA features.
Topics: Aged; Algorithms; Brain; Brain Mapping; Decision Trees; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Principal Component Analysis; Regression Analysis | 2015 |
Correlating Parkinson's disease motor symptoms with three-dimensional [(18)F]FP-CIT PET.
Topics: Aged; Aged, 80 and over; Brain; Cross-Sectional Studies; Female; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Male; Middle Aged; Movement Disorders; Multimodal Imaging; Parkinson Disease; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed; Tropanes | 2015 |
Dopaminergic correlates of metabolic network activity in Parkinson's disease.
Topics: Adult; Brain; Brain Mapping; Dopamine; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Levodopa; Male; Middle Aged; Neural Pathways; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals | 2015 |
Deficient vesicular storage: A common theme in catecholaminergic neurodegeneration.
Topics: Autopsy; Catecholamines; Fluorodeoxyglucose F18; Humans; Levodopa; Neurodegenerative Diseases; Neurons; Parkinson Disease; Putamen; Synaptic Vesicles | 2015 |
Brain metabolic abnormalities during gait with freezing in Parkinson's disease.
Topics: Aged; Brain; Cluster Analysis; Female; Fluorodeoxyglucose F18; Gait Disorders, Neurologic; Humans; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Positron-Emission Tomography; Severity of Illness Index; Statistics, Nonparametric | 2015 |
Metabolic Topology of Neurodegenerative Disorders: Influence of Cognitive and Motor Deficits.
Topics: Aged; Alzheimer Disease; Brain Mapping; Cognition; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lewy Body Disease; Male; Movement Disorders; Neurodegenerative Diseases; Parkinson Disease; Parkinson Disease, Postencephalitic; Radionuclide Imaging; Radiopharmaceuticals | 2015 |
Different loss of dopamine transporter according to subtype of multiple system atrophy.
Topics: Adult; Aged; Brain; Corpus Striatum; Dopamine Plasma Membrane Transport Proteins; Dopaminergic Neurons; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multiple System Atrophy; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tropanes | 2016 |
Hypometabolism in Posterior and Temporal Areas of the Brain is Associated with Cognitive Decline in Parkinson's Disease.
Topics: Brain; Cognition Disorders; Fluorodeoxyglucose F18; Humans; Mental Status Schedule; Parkinson Disease; Positron-Emission Tomography; Temporal Lobe | 2015 |
Significance of visual hallucinations and cerebral hypometabolism in the risk of dementia in Parkinson's disease patients with mild cognitive impairment.
Topics: Aged; Brain; Brain Mapping; Cognitive Dysfunction; Comorbidity; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hallucinations; Humans; Male; Neuropsychological Tests; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; Risk Factors | 2016 |
Putaminal dopamine turnover in de novo Parkinson disease predicts later motor complications.
Topics: Aged; Dihydroxyphenylalanine; Dopamine; Dopamine Agents; Dyskinesias; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Putamen; Single-Blind Method | 2016 |
The Neural Basis of Postural Instability Gait Disorder Subtype of Parkinson's Disease: A PET and fMRI Study.
Topics: Aged; Cognition Disorders; Female; Fluorodeoxyglucose F18; Gait Disorders, Neurologic; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Oxygen; Parkinson Disease; Positron-Emission Tomography; Postural Balance; Severity of Illness Index; Tremor | 2016 |
Serial MRI findings in a case of the Parkinson variant of multiple system atrophy: Clinical usefulness of diffusion-weighted imaging at B1000 in early stages of the disease.
Topics: Brain Stem; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Longitudinal Studies; Middle Aged; Multiple System Atrophy; Parkinson Disease; Positron-Emission Tomography; Retrospective Studies | 2016 |
Does Microglial Activation Influence Hippocampal Volume and Neuronal Function in Alzheimer's Disease and Parkinson's Disease Dementia?
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Antineoplastic Agents; Brain Mapping; Cognition; Female; Fluorodeoxyglucose F18; Hippocampus; Humans; Isoquinolines; Magnetic Resonance Imaging; Male; Microglia; Middle Aged; Neurons; Neuropsychological Tests; Parkinson Disease; Positron-Emission Tomography; Psychiatric Status Rating Scales; Supranuclear Palsy, Progressive | 2016 |
Cerebral Metabolic Differences Associated with Cognitive Impairment in Parkinson's Disease.
Topics: Aged; Brain; Cerebral Cortex; Cognitive Dysfunction; Dementia; Female; Fluorodeoxyglucose F18; Humans; Levodopa; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Positron-Emission Tomography | 2016 |
Parkinson's disease-related network topographies characterized with resting state functional MRI.
Topics: Adult; Aged; Antiparkinson Agents; Brain; Brain Mapping; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Levodopa; Logistic Models; Magnetic Resonance Imaging; Male; Middle Aged; Neural Pathways; Oxygen; Parkinson Disease; Positron-Emission Tomography; Reproducibility of Results; Rest | 2017 |
Functional neuroimaging and clinical features of drug naive patients with de novo Parkinson's disease and probable RBD.
Topics: Aged; Brain; Female; Fluorodeoxyglucose F18; Functional Neuroimaging; Humans; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Positron-Emission Tomography; REM Sleep Behavior Disorder; Tomography, Emission-Computed, Single-Photon; Tropanes | 2016 |
Behavioural and neuroimaging correlates of impaired self-awareness of hypo- and hyperkinesia in Parkinson's disease.
Topics: Aged; Agnosia; Awareness; Brain; Brain Mapping; Female; Fluorodeoxyglucose F18; Humans; Hyperkinesis; Hypokinesia; Male; Middle Aged; Neuroimaging; Neuropsychological Tests; Parkinson Disease; Positron-Emission Tomography | 2016 |
Occupancy of pramipexole (Sifrol) at cerebral dopamine D2/3 receptors in Parkinson's disease patients.
Topics: Aged; Benzamides; Benzothiazoles; Dopamine Agonists; Dopamine Antagonists; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Pramipexole; Radiopharmaceuticals; Receptors, Dopamine D2; Receptors, Dopamine D3 | 2016 |
Elevated cerebrospinal fluid ratios of cysteinyl-dopamine/3,4-dihydroxyphenylacetic acid in parkinsonian synucleinopathies.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aged; Animals; Catechols; Dihydroxyphenylalanine; Dopamine; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multiple System Atrophy; Parkinson Disease; PC12 Cells; Putamen; Rats | 2016 |
Dissociation of metabolic and hemodynamic levodopa responses in the 6-hydroxydopamine rat model.
Topics: Analgesics; Animals; Antiparkinson Agents; Cerebrovascular Circulation; Disease Models, Animal; Female; Fluorodeoxyglucose F18; Hemodynamics; Isoflurane; Ketamine; Levodopa; Oxidopamine; Parkinson Disease; Positron-Emission Tomography; Rats; Rats, Sprague-Dawley; Sympatholytics | 2016 |
Fatigue in Parkinson's disease: The contribution of cerebral metabolic changes.
Topics: Aged; Brain; Fatigue; Female; Fluorodeoxyglucose F18; Glucose; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Positron-Emission Tomography; Statistics as Topic | 2017 |
Brain glucose metabolism changes in Parkinson's disease patients with CHCHD2 mutation based on (18)F-FDG PET imaging.
Topics: Adult; Brain; DNA-Binding Proteins; Family Health; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Mitochondrial Proteins; Mutation; Parkinson Disease; Positron-Emission Tomography; Transcription Factors | 2016 |
Suite PET/CT neuroimaging for the diagnosis of Parkinson's disease: statistical parametric mapping analysis.
Topics: Adult; Aged; Aged, 80 and over; Brain; Brain Mapping; Case-Control Studies; Cocaine; Dopamine Plasma Membrane Transport Proteins; Female; Fluorodeoxyglucose F18; Functional Neuroimaging; Glucose; Humans; Male; Middle Aged; Molecular Imaging; Parkinson Disease; Positron Emission Tomography Computed Tomography; Raclopride; Radiopharmaceuticals; Receptors, Dopamine D2; Young Adult | 2017 |
Apomorphine pump in advanced Parkinson's disease: Effects on motor and nonmotor symptoms with brain metabolism correlations.
Topics: Aged; Apomorphine; Brain; Dopamine Agonists; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Motor Activity; Parkinson Disease; Positron-Emission Tomography; Severity of Illness Index; Statistics as Topic; Statistics, Nonparametric | 2017 |
Longitudinal study of cognitive and cerebral metabolic changes in Parkinson's disease.
Topics: Aged; Aged, 80 and over; Cerebral Cortex; Cognition Disorders; Cross-Sectional Studies; Dementia; Female; Fluorodeoxyglucose F18; Humans; Longitudinal Studies; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Positron-Emission Tomography; Severity of Illness Index | 2017 |
Striatofrontal Deafferentiation in MSA-P: Evaluation with [18F]FDG Brain PET.
Topics: Brain; Brain Mapping; Case-Control Studies; Cerebral Cortex; Corpus Striatum; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Multiple System Atrophy; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals | 2017 |
The effect of 18F-FDG-PET image reconstruction algorithms on the expression of characteristic metabolic brain network in Parkinson's disease.
Topics: Algorithms; Brain; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Parkinson Disease; Positron-Emission Tomography; Reproducibility of Results | 2017 |
Urinary dysfunction in early de novo patients with Parkinson's disease.
Topics: alpha-Synuclein; Fluorodeoxyglucose F18; Humans; Kidney Diseases; Parkinson Disease; Tropanes | 2017 |
Modified Fluorodeoxyglucose Metabolism in Motor Circuitry by Subthalamic Deep Brain Stimulation.
Topics: Aged; Deep Brain Stimulation; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Motor Cortex; Nerve Net; Parkinson Disease; Positron-Emission Tomography; Subthalamic Nucleus | 2017 |
Comparison of cerebral glucose metabolism between multiple system atrophy Parkinsonian type and Parkinson's disease.
Topics: Adult; Aged; Biomarkers; Brain Mapping; Cerebral Cortex; Corpus Striatum; Diagnosis, Differential; Energy Metabolism; Female; Fluorodeoxyglucose F18; Functional Laterality; Glucose; Humans; Male; Middle Aged; Multiple System Atrophy; Parkinson Disease; Positron-Emission Tomography; Predictive Value of Tests; Thalamus | 2008 |
Genetic screening for LRRK2 gene G2019S mutation in Parkinson's disease patients from Southern Italy.
Topics: Adult; Age of Onset; Aged; DNA Mutational Analysis; Female; Fluorodeoxyglucose F18; Gene Frequency; Genetic Predisposition to Disease; Genetic Testing; Genotype; Glycine; Humans; Italy; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Protein Serine-Threonine Kinases; Serine; Young Adult | 2009 |
Diagnostic value of brain MRI and 18F-FDG PET in the differentiation of Parkinsonian-type multiple system atrophy from Parkinson's disease.
Topics: Adult; Aged; Cerebellum; Diffusion Magnetic Resonance Imaging; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Multiple System Atrophy; Parkinson Disease; Pons; Positron-Emission Tomography; Putamen; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Single-Blind Method | 2008 |
Functional brain imaging in pure akinesia with gait freezing: [18F] FDG PET and [18F] FP-CIT PET analyses.
Topics: Aged; Aged, 80 and over; Basal Ganglia Diseases; Brain; Carbon Radioisotopes; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gait Disorders, Neurologic; Glucose; Humans; Hypokinesia; Iodine Radioisotopes; Magnetic Resonance Imaging; Male; Mesencephalon; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; Supranuclear Palsy, Progressive; Tropanes | 2009 |
[Cerebral glucose metabolism in Parkinson's disease with dementia].
Topics: Aged; Aged, 80 and over; Brain; Case-Control Studies; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Parkinson Disease; Radionuclide Imaging | 2008 |
A follow-up study on 6-[18F]fluoro-L-dopa uptake in early Parkinson's disease shows nonlinear progression in the putamen.
Topics: Aged; Brain Mapping; Disease Progression; Female; Fluorodeoxyglucose F18; Functional Laterality; Humans; Levodopa; Longitudinal Studies; Male; Middle Aged; Nonlinear Dynamics; Parkinson Disease; Positron-Emission Tomography; Postmortem Changes; Putamen; Time Factors | 2009 |
Assessing the microlesion effect of subthalamic deep brain stimulation surgery with FDG PET.
Topics: Aged; Deep Brain Stimulation; Electrodes, Implanted; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Subthalamus | 2009 |
Do parkinsonian patients have trouble telling lies? The neurobiological basis of deceptive behaviour.
Topics: Aged; Case-Control Studies; Deception; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Positron-Emission Tomography; Prefrontal Cortex; Radiopharmaceuticals | 2009 |
Differential diagnosis of parkinsonian syndromes using PCA-based functional imaging features.
Topics: Adult; Algorithms; Artificial Intelligence; Brain; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Male; Middle Aged; Parkinson Disease; Pattern Recognition, Automated; Principal Component Analysis; Radiography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2009 |
Subcortical elevation of metabolism in Parkinson's disease--a critical reappraisal in the context of global mean normalization.
Topics: Brain; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Models, Neurological; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; Up-Regulation | 2009 |
Cortical hypometabolism assessed by a metabolic ratio in Parkinson's disease primarily reflects cognitive deterioration-[18F]FDG-PET.
Topics: Aged; Aged, 80 and over; Brain Mapping; Cerebral Cortex; Chi-Square Distribution; Cognition Disorders; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multivariate Analysis; Neurologic Examination; Neuropsychological Tests; Parkinson Disease; Positron-Emission Tomography; Severity of Illness Index; Statistics, Nonparametric | 2009 |
Association of DRD3 and GRIN2B with impulse control and related behaviors in Parkinson's disease.
Topics: Aged; Brain Mapping; Carbon Isotopes; Disruptive, Impulse Control, and Conduct Disorders; Family Health; Female; Fluorodeoxyglucose F18; Gene Dosage; Gene Frequency; Genetic Predisposition to Disease; Genotype; Humans; Impulsive Behavior; Magnetic Resonance Imaging; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Receptors, Dopamine D3; Receptors, N-Methyl-D-Aspartate; Serotonin Plasma Membrane Transport Proteins | 2009 |
Expanding the clinical phenotype of SNCA duplication carriers.
Topics: Adult; Aged; alpha-Synuclein; Brain; Carbon Isotopes; Chromosome Mapping; Cocaine; Family Health; Female; Fluorodeoxyglucose F18; Gene Dosage; Gene Duplication; Genetic Predisposition to Disease; Humans; Male; Middle Aged; Parkinson Disease; Phenotype; Positron-Emission Tomography; Raclopride; REM Sleep Behavior Disorder; Sensory Thresholds; Smell; Young Adult | 2009 |
Brain metabolic correlates of dopaminergic degeneration in de novo idiopathic Parkinson's disease.
Topics: Algorithms; Brain; Dopamine; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Least-Squares Analysis; Male; Middle Aged; Motor Activity; Neostriatum; Parkinson Disease; Positron-Emission Tomography; Tomography, Emission-Computed, Single-Photon; Tropanes | 2010 |
What can man do without basal ganglia motor output? The effect of combined unilateral subthalamotomy and pallidotomy in a patient with Parkinson's disease.
Topics: Aged; Basal Ganglia; Biomechanical Phenomena; Executive Function; Fluorodeoxyglucose F18; Functional Laterality; Globus Pallidus; Humans; Learning; Magnetic Resonance Imaging; Male; Motor Cortex; Neurosurgical Procedures; Parkinson Disease; Posture; Psychomotor Performance; Radionuclide Imaging; Radiopharmaceuticals; Reaction Time; Subthalamic Nucleus; Time Perception; Transcranial Magnetic Stimulation | 2009 |
Complementary acupuncture treatment increases cerebral metabolism in patients with Parkinson's disease.
Topics: Acupuncture Therapy; Aged; Antiparkinson Agents; Benserazide; Brain Chemistry; Combined Modality Therapy; Drug Combinations; Energy Metabolism; Female; Fluorodeoxyglucose F18; Glucose; Humans; Image Processing, Computer-Assisted; Levodopa; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals | 2009 |
In vivo assessment of brain monoamine systems in parkin gene carriers: a PET study.
Topics: Adult; Aged; Biogenic Monoamines; Brain; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Mutation; Parkinson Disease; Positron-Emission Tomography; Protein Kinases; Statistics, Nonparametric; Ubiquitin-Protein Ligases | 2010 |
Parkinson's disease spatial covariance pattern: noninvasive quantification with perfusion MRI.
Topics: Aged; Brain Chemistry; Cerebrovascular Circulation; Data Interpretation, Statistical; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Parkinson Disease; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals | 2010 |
Parkinson's disease and growth factors - are they the answer?
Topics: Animals; Fluorodeoxyglucose F18; Glial Cell Line-Derived Neurotrophic Factor; History, 20th Century; History, 21st Century; Humans; Intercellular Signaling Peptides and Proteins; Multicenter Studies as Topic; Neurons; Parkinson Disease; Positron-Emission Tomography; Randomized Controlled Trials as Topic | 2009 |
Abnormalities in metabolic network activity precede the onset of motor symptoms in Parkinson's disease.
Topics: Aged; Analysis of Variance; Brain Mapping; Cerebrovascular Circulation; Cognition Disorders; Corpus Striatum; Dopamine Plasma Membrane Transport Proteins; Female; Fluorodeoxyglucose F18; Functional Laterality; Humans; Longitudinal Studies; Male; Metabolic Networks and Pathways; Middle Aged; Motor Activity; Parkinson Disease; Positron-Emission Tomography; Protein Binding; Statistics as Topic; Time Factors | 2010 |
Neurotransmitter changes in dementia with Lewy bodies and Parkinson disease dementia in vivo.
Topics: Acetylcholine; Aged; Brain; Brain Mapping; Dihydroxyphenylalanine; Dopamine; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Lewy Bodies; Lewy Body Disease; Middle Aged; Neuropsychological Tests; Parkinson Disease; Positron-Emission Tomography | 2010 |
Subthalamic nucleus stimulation affects theory of mind network: a PET study in Parkinson's disease.
Topics: Aged; Brain Mapping; Case-Control Studies; Deep Brain Stimulation; Emotions; Female; Fluorodeoxyglucose F18; Glucose; Humans; Limbic System; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Subthalamic Nucleus | 2010 |
Hemiparkinsonism and hemiatrophy syndrome: a rare observation.
Topics: Atrophy; Brain Chemistry; Dopamine Plasma Membrane Transport Proteins; Dystonia; Female; Fluorodeoxyglucose F18; Functional Laterality; Gait Disorders, Neurologic; Humans; Middle Aged; Muscle Weakness; Neurologic Examination; Parkinson Disease; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon | 2010 |
Deep brain stimulation of pedunculopontine tegmental nucleus (PPTg) promotes cognitive and metabolic changes: a target-specific effect or response to a low-frequency pattern of stimulation?
Topics: Aged; Cognition; Cognition Disorders; Deep Brain Stimulation; Female; Fluorodeoxyglucose F18; Humans; Male; Metabolic Clearance Rate; Parkinson Disease; Pedunculopontine Tegmental Nucleus; Radionuclide Imaging; Radiopharmaceuticals; Treatment Outcome | 2010 |
Cerebral glucose metabolism of Parkinson's disease patients with mild cognitive impairment.
Topics: Aged; Brain; Brain Mapping; Case-Control Studies; Cerebral Cortex; Cognition Disorders; Dementia; Female; Fluorodeoxyglucose F18; Humans; Male; Mental Status Schedule; Middle Aged; Neuropsychological Tests; Parkinson Disease; Positron-Emission Tomography | 2010 |
Gaucher disease ascertained through a Parkinson's center: imaging and clinical characterization.
Topics: Adult; Aged; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Gaucher Disease; Glucosylceramidase; Humans; Male; Middle Aged; Mutation; Neuropsychological Tests; Olfaction Disorders; Parkinson Disease; Phenotype; Positron-Emission Tomography; Ultrasonography, Doppler, Transcranial | 2010 |
Glucose metabolism in progressive nonfluent aphasia with and without parkinsonism.
Topics: Aged; Basal Ganglia Diseases; Female; Fluorodeoxyglucose F18; Glucose; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Primary Progressive Nonfluent Aphasia; Radiopharmaceuticals; Retrospective Studies; Supranuclear Palsy, Progressive | 2010 |
Parkinson's disease tremor-related metabolic network: characterization, progression, and treatment effects.
Topics: Aged; Brain; Deep Brain Stimulation; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; Tremor | 2011 |
[(11)C]PIB-, [(18)F]FDG-PET and MRI imaging in patients with Parkinson's disease with and without dementia.
Topics: Aged; Aged, 80 and over; Aniline Compounds; Atrophy; Benzothiazoles; Cerebellum; Dementia; Female; Fluorodeoxyglucose F18; Frontal Lobe; Glucose; Hippocampus; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; Thiazoles | 2010 |
The effect of age on motor deficits and cerebral glucose metabolism of Parkinson's disease.
Topics: Aged; Aged, 80 and over; Aging; Case-Control Studies; Cerebral Cortex; Fluorodeoxyglucose F18; Glucose; Humans; Middle Aged; Movement Disorders; Parkinson Disease; Positron-Emission Tomography | 2011 |
Platelet mitochondrial complex I and I+III activities do not correlate with cerebral mitochondrial oxidative metabolism.
Topics: Adult; Aged; Blood Platelets; Brain; Brain Chemistry; Electron Transport Complex I; Electron Transport Complex III; Female; Fluorodeoxyglucose F18; Glucose; Humans; Huntington Disease; Image Processing, Computer-Assisted; Kinetics; Male; Middle Aged; Mitochondria; Oxidation-Reduction; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals | 2011 |
Pedunculopontine nucleus deep brain stimulation produces sustained improvement in primary progressive freezing of gait.
Topics: Aged; Deep Brain Stimulation; Fluorodeoxyglucose F18; Gait; Humans; Male; Movement Disorders; Parkinson Disease; Pedunculopontine Tegmental Nucleus; Positron-Emission Tomography; Radiopharmaceuticals; Treatment Outcome | 2011 |
Age-specific progression of nigrostriatal dysfunction in Parkinson's disease.
Topics: Adult; Aged; Aging; Carbon Isotopes; Corpus Striatum; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Longitudinal Studies; Male; Methylphenidate; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Protein Binding; Substantia Nigra; Tetrabenazine; Tritium; Young Adult | 2011 |
Illusory misidentifications and cortical hypometabolism in Parkinson's disease.
Topics: Aged; Analysis of Variance; Brain Mapping; Cerebral Cortex; Female; Fluorodeoxyglucose F18; Functional Laterality; Humans; Illusions; Magnetic Resonance Imaging; Male; Mental Status Schedule; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; Recognition, Psychology; Visual Acuity | 2011 |
Brain energization in response to deep brain stimulation of subthalamic nuclei in Parkinson's disease.
Topics: Adult; Deep Brain Stimulation; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; Subthalamic Nucleus | 2011 |
Cerebral glucose metabolic features of Parkinson disease and incident dementia: longitudinal study.
Topics: Adult; Aged; Brain Chemistry; Cerebral Cortex; Cognition; Cohort Studies; Dementia; Disease Progression; Female; Fluorodeoxyglucose F18; Glucose; Humans; Longitudinal Studies; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals | 2011 |
Mild cognitive impairment in drug-naive patients with PD is associated with cerebral hypometabolism.
Topics: Aged; Analysis of Variance; Brain Mapping; Case-Control Studies; Cerebral Cortex; Chi-Square Distribution; Cognition Disorders; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Positron-Emission Tomography | 2011 |
DJ-1 and αSYN in LRRK2 CSF do not correlate with striatal dopaminergic function.
Topics: alpha-Synuclein; Biomarkers; Carbon Isotopes; Corpus Striatum; Dopamine; Female; Fluorodeoxyglucose F18; Humans; Intracellular Signaling Peptides and Proteins; Japan; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Luria-Nebraska Neuropsychological Battery; Male; Methylphenidate; Norway; Oncogene Proteins; Parkinson Disease; Positron-Emission Tomography; Protein Deglycase DJ-1; Protein Serine-Threonine Kinases; Statistics as Topic; Tetrabenazine; United States | 2012 |
18F-FDG PET study on the idiopathic Parkinson's disease from several parkinsonian-plus syndromes.
Topics: Aged; Aged, 80 and over; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lewy Body Disease; Male; Middle Aged; Multiple System Atrophy; Parkinson Disease; Positron-Emission Tomography; Supranuclear Palsy, Progressive; Syndrome | 2012 |
Fluorodeoxyglucose positron emission tomography in Richardson’s syndrome and progressive supranuclear palsy-parkinsonism.
Topics: Aged; Brain; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Putamen; ROC Curve; Severity of Illness Index; Supranuclear Palsy, Progressive; Thalamus | 2012 |
Compensatory premotor activity during affective face processing in subclinical carriers of a single mutant Parkin allele.
Topics: Adult; Alleles; Analysis of Variance; Brain; Case-Control Studies; Executive Function; Face; Facial Expression; Family Health; Female; Fluorodeoxyglucose F18; Functional Laterality; Humans; Image Processing, Computer-Assisted; Levodopa; Linear Models; Magnetic Resonance Imaging; Male; Middle Aged; Mutation; Oxygen; Parkinson Disease; Pattern Recognition, Visual; Photic Stimulation; Positron-Emission Tomography; Recognition, Psychology; Self Report; Severity of Illness Index; Ubiquitin-Protein Ligases | 2012 |
Network correlates of disease severity in multiple system atrophy.
Topics: Biomarkers; Brain; Case-Control Studies; Female; Fluorodeoxyglucose F18; Functional Neuroimaging; Humans; Male; Middle Aged; Models, Statistical; Multiple System Atrophy; Parkinson Disease; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Severity of Illness Index | 2012 |
Changes in brain glucose metabolism in subthalamic nucleus deep brain stimulation for advanced Parkinson's disease.
Topics: Aged; Brain; Case-Control Studies; Deep Brain Stimulation; Female; Fluorodeoxyglucose F18; Frontal Lobe; Glucose; Gyrus Cinguli; Humans; Male; Middle Aged; Parietal Lobe; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; Subthalamic Nucleus | 2012 |
Feasibility of [18F]-2-Fluoro-A85380-PET imaging of human vascular nicotinic acetylcholine receptors in vivo.
Topics: Aged; Aged, 80 and over; Aorta, Thoracic; Azetidines; Carotid Arteries; Case-Control Studies; Feasibility Studies; Female; Fluorodeoxyglucose F18; Germany; Humans; Male; Middle Aged; Multimodal Imaging; Multiple System Atrophy; Parkinson Disease; Positron-Emission Tomography; Receptors, Nicotinic; Tomography, X-Ray Computed | 2012 |
Imaging vascular nicotine receptors: a new window onto vascular disease.
Topics: Aorta, Thoracic; Azetidines; Carotid Arteries; Female; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Multiple System Atrophy; Parkinson Disease; Positron-Emission Tomography; Receptors, Nicotinic; Tomography, X-Ray Computed | 2012 |
Alternative normalization methods demonstrate widespread cortical hypometabolism in untreated de novo Parkinson's disease.
Topics: Aged; Case-Control Studies; Cerebral Cortex; Female; Fluorodeoxyglucose F18; Glucose; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography | 2012 |
Posterior parietooccipital hypometabolism may differentiate mild cognitive impairment from dementia in Parkinson's disease.
Topics: Aged; Case-Control Studies; Cognitive Dysfunction; Dementia; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Multimodal Imaging; Occipital Lobe; Parietal Lobe; Parkinson Disease; Positron-Emission Tomography; Tomography, X-Ray Computed | 2012 |
Zolpidem improves neuropsychiatric symptoms and motor dysfunction in a patient with Parkinson's disease after deep brain stimulation.
Topics: Confusion; Deep Brain Stimulation; Female; Fluorodeoxyglucose F18; Humans; Hypnotics and Sedatives; Magnetic Resonance Imaging; Middle Aged; Motor Activity; Parkinson Disease; Positron-Emission Tomography; Psychiatric Status Rating Scales; Pyridines; Subthalamus; Zolpidem | 2012 |
[¹⁸F]FDG-PET is superior to [¹²³I]IBZM-SPECT for the differential diagnosis of parkinsonism.
Topics: Aged; Diagnosis, Differential; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Iodobenzenes; Lewy Body Disease; Male; Middle Aged; Multiple System Atrophy; Neurodegenerative Diseases; Parkinson Disease; Parkinsonian Disorders; Positron-Emission Tomography; Supranuclear Palsy, Progressive; Tomography, Emission-Computed, Single-Photon | 2012 |
Abnormal network topographies and changes in global activity: absence of a causal relationship.
Topics: Adult; Aged; Analysis of Variance; Brain; Brain Chemistry; Causality; Cerebellum; Cerebral Cortex; Data Interpretation, Statistical; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Nerve Net; Parkinson Disease; Positron-Emission Tomography; Principal Component Analysis; Radiopharmaceuticals; Sleep; Thalamus | 2012 |
Progressive changes in a recognition memory network in Parkinson's disease.
Topics: Aged; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Longitudinal Studies; Magnetic Resonance Imaging; Male; Memory Disorders; Middle Aged; Models, Neurological; Nerve Net; Neuropsychological Tests; Parkinson Disease; Principal Component Analysis; Psychomotor Performance; Radionuclide Imaging; Radiopharmaceuticals; Reaction Time; Recognition, Psychology; Socioeconomic Factors | 2013 |
[A study on the cerebral glucose metabolism in progressive supranuclear palsy].
Topics: Aged; Brain; Case-Control Studies; Dementia; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Supranuclear Palsy, Progressive | 2012 |
Clinical, 18F-dopa PET, and genetic analysis of an ethnic Chinese kindred with early-onset parkinsonism and parkin gene mutations.
Topics: Adult; Alleles; Asian People; Caudate Nucleus; Chromosome Deletion; Chromosomes, Human, Pair 6; Dominance, Cerebral; Dopamine; Female; Fluorodeoxyglucose F18; Haplotypes; Humans; Ligases; Male; Mutation; Parkinson Disease; Pedigree; Putamen; Receptors, Presynaptic; RNA, Messenger; Taiwan; Tomography, Emission-Computed; Ubiquitin-Protein Ligases | 2002 |
Monosymptomatic resting tremor and Parkinson's disease: a multitracer positron emission tomographic study.
Topics: Adult; Aged; Brain; Cerebellum; Dihydroxyphenylalanine; Dominance, Cerebral; Energy Metabolism; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neurologic Examination; Parkinson Disease; Putamen; Raclopride; Receptors, Dopamine D2; Reference Values; Tomography, Emission-Computed; Tremor; Up-Regulation | 2002 |
Deep brain stimulation of the subthalamic nucleus versus levodopa challenge in Parkinson's disease: measuring the on- and off-conditions with FDG-PET.
Topics: Aged; Antiparkinson Agents; Brain Chemistry; Electric Stimulation Therapy; Fluorodeoxyglucose F18; Functional Laterality; Gait; Glucose; Humans; Levodopa; Male; Parkinson Disease; Radiopharmaceuticals; Subthalamic Nucleus; Tomography, Emission-Computed | 2002 |
Differentiating multiple system atrophy from Parkinson's disease: contribution of striatal and midbrain MRI volumetry and multi-tracer PET imaging.
Topics: Atrophy; Corpus Striatum; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Mesencephalon; Middle Aged; Parkinson Disease; Putamen; Radiopharmaceuticals; Tomography, Emission-Computed | 2002 |
[Measurement of brain function by positron emission tomography: from mapping to synaptic function].
Topics: Adult; Brain; Brain Mapping; Brain Neoplasms; Cerebrovascular Circulation; Female; Fluorodeoxyglucose F18; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Moyamoya Disease; Parkinson Disease; Synaptic Transmission; Tomography, Emission-Computed | 2002 |
Endogenous dopamine release after pharmacological challenges in Parkinson's disease.
Topics: Aged; Binding Sites; Dopamine; Dopamine Antagonists; Dopamine Uptake Inhibitors; Female; Fluorodeoxyglucose F18; Humans; Male; Methamphetamine; Middle Aged; Parkinson Disease; Putamen; Raclopride; Radiopharmaceuticals; Severity of Illness Index; Synapses; Tomography, Emission-Computed | 2003 |
Transplantation in Parkinson's disease: PET changes correlate with the amount of grafted tissue.
Topics: Aged; Corpus Striatum; Dopamine Plasma Membrane Transport Proteins; Female; Fetal Tissue Transplantation; Fluorodeoxyglucose F18; Graft Rejection; Humans; Immunosuppressive Agents; Male; Membrane Glycoproteins; Membrane Transport Proteins; Mesencephalon; Middle Aged; Nerve Tissue Proteins; Parkinson Disease; Radiopharmaceuticals; Tomography, Emission-Computed | 2003 |
Cognitive- and motor-related regions in Parkinson's disease: FDOPA and FDG PET studies.
Topics: Biological Transport; Brain; Brain Mapping; Cognition; Dihydroxyphenylalanine; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Functional Laterality; Humans; Male; Middle Aged; Motor Activity; Parkinson Disease; Radiopharmaceuticals; Regression Analysis; Tomography, Emission-Computed | 2004 |
Executive processes in Parkinson's disease: FDG-PET and network analysis.
Topics: Adult; Aged; Brain; Corpus Striatum; Female; Fluorodeoxyglucose F18; Frontal Lobe; Humans; Male; Middle Aged; Movement; Nerve Net; Neural Networks, Computer; Neural Pathways; Parkinson Disease; Tomography, Emission-Computed | 2004 |
Visual hallucination in Parkinson's disease with FDG PET.
Topics: Aged; Brain; Female; Fluorodeoxyglucose F18; Frontal Lobe; Functional Laterality; Glucose; Hallucinations; Humans; Male; Memory Disorders; Occipital Lobe; Parkinson Disease; Prefrontal Cortex; Radiopharmaceuticals; Severity of Illness Index; Tomography, Emission-Computed | 2004 |
Different metabolic patterns analysis of Parkinsonism on the 18F-FDG PET.
Topics: Aged; Brain; Case-Control Studies; Caudate Nucleus; Cerebellum; Female; Fluorodeoxyglucose F18; Glucose; Gyrus Cinguli; Humans; Male; Mesencephalon; Middle Aged; Multiple System Atrophy; Neocortex; Parkinson Disease; Parkinsonian Disorders; Pons; Positron-Emission Tomography; Putamen; Radiopharmaceuticals; Retrospective Studies; Supranuclear Palsy, Progressive; Thalamus | 2004 |
Brain parenchyma sonography detects preclinical parkinsonism.
Topics: Adult; Aged; Aged, 80 and over; Alleles; Brain; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Parkinson Disease; Point Mutation; Positron-Emission Tomography; Radiopharmaceuticals; Substantia Nigra; Ubiquitin-Protein Ligases; Ultrasonography | 2004 |
Functional recovery in a primate model of Parkinson's disease following motor cortex stimulation.
Topics: Animals; Chronic Disease; Disease Models, Animal; Electric Stimulation; Electrophysiology; Fluorodeoxyglucose F18; Motor Cortex; Movement Disorders; MPTP Poisoning; Papio; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; Recovery of Function | 2004 |
[18F]FDOPA PET and clinical features in parkinsonism due to manganism.
Topics: Adult; Antiparkinson Agents; Brain; Carbidopa; Drug Combinations; Female; Fluorodeoxyglucose F18; Gait; Humans; Levodopa; Magnetic Resonance Imaging; Manganese Poisoning; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals | 2005 |
The metabolic pathology of dopa-responsive dystonia.
Topics: Adult; Brain; Brain Mapping; Dystonia; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Levodopa; Male; Parkinson Disease; Positron-Emission Tomography | 2005 |
Direct comparison between regional cerebral metabolism in progressive supranuclear palsy and Parkinson's disease.
Topics: Aged; Blood Glucose; Brain Mapping; Cerebral Cortex; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Regional Blood Flow; Supranuclear Palsy, Progressive | 2005 |
Voxel based comparison of glucose metabolism in the differential diagnosis of the multiple system atrophy using statistical parametric mapping.
Topics: Aged; Aged, 80 and over; Brain; Brain Mapping; Case-Control Studies; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Glucose; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Multiple System Atrophy; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals | 2005 |
In vivo detection of iron and neuromelanin by transcranial sonography: a new approach for early detection of substantia nigra damage.
Topics: Apoferritins; Early Diagnosis; Female; Ferritins; Fluorodeoxyglucose F18; Humans; Iron; Male; Melanins; Middle Aged; Nerve Degeneration; Parkinson Disease; Radiopharmaceuticals; Substantia Nigra; Ultrasonography, Doppler, Transcranial | 2005 |
Nigral degeneration and striatal dopaminergic dysfunction in idiopathic and Parkin-linked Parkinson's disease.
Topics: Adult; Caudate Nucleus; Corpus Striatum; Dopamine; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nerve Degeneration; Parkinson Disease; Point Mutation; Positron-Emission Tomography; Putamen; Radiopharmaceuticals; Substantia Nigra; Ubiquitin-Protein Ligases | 2006 |
Corticostriatal covariance patterns of 6-[18F]fluoro-L-dopa and [18F]fluorodeoxyglucose PET in Parkinson's disease.
Topics: Aged; Cerebral Cortex; Corpus Striatum; Diagnosis, Differential; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Functional Laterality; Humans; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Sex Factors | 2006 |
Network modulation by the subthalamic nucleus in the treatment of Parkinson's disease.
Topics: Aged; Analysis of Variance; Blood Glucose; Brain Mapping; Cerebellum; Cerebral Cortex; Corpus Striatum; Deep Brain Stimulation; Energy Metabolism; Female; Fluorodeoxyglucose F18; Globus Pallidus; Gyrus Cinguli; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Nerve Net; Neural Pathways; Parkinson Disease; Positron-Emission Tomography; Subthalamic Nucleus; Thalamus | 2006 |
Feasibility of 2-deoxy-2-[18F]fluoro-D-glucose- A85380-PET for imaging of human cardiac nicotinic acetylcholine receptors in vivo.
Topics: Aged; Feasibility Studies; Female; Fluorodeoxyglucose F18; Heart; Heart Ventricles; Humans; Male; Middle Aged; Multiple System Atrophy; Myocardium; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Nicotinic | 2006 |
Striatal dopa and glucose metabolism in PD patients with freezing of gait.
Topics: Blood Glucose; Brain Mapping; Corpus Striatum; Dihydroxyphenylalanine; Dominance, Cerebral; Female; Fluorodeoxyglucose F18; Gait Apraxia; Humans; Male; Neurologic Examination; Occipital Lobe; Parietal Lobe; Parkinson Disease; Positron-Emission Tomography; Putamen | 2006 |
Putamen FDOPA uptake and its relationship tot cognitive functioning in PD.
Topics: Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Levodopa; Memory; Models, Biological; Neuropsychological Tests; Parkinson Disease; Problem Solving; Putamen; Tomography, Emission-Computed | 2006 |
Neuroscience. A better view of brain disorders.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Brain; Brain Chemistry; Brain Diseases; Brain Mapping; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Obsessive-Compulsive Disorder; Pain; Pain Management; Parkinson Disease; Positron-Emission Tomography | 2006 |
Parkinsonism in type I Gaucher's disease.
Topics: 3-Iodobenzylguanidine; Adult; Age of Onset; Brain; Fluorodeoxyglucose F18; Gaucher Disease; Heart; Humans; Male; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon | 2006 |
Metabolic brain networks associated with cognitive function in Parkinson's disease.
Topics: Brain; Cognition; Cognition Disorders; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Metabolic Networks and Pathways; Middle Aged; Nerve Net; Neuropsychological Tests; Parkinson Disease; Positron-Emission Tomography; Principal Component Analysis; Reproducibility of Results | 2007 |
FDG-PET study of the bilateral subthalamic nucleus stimulation effects on the regional cerebral metabolism in advanced Parkinson disease.
Topics: Antiparkinson Agents; Brain; Brain Mapping; Deep Brain Stimulation; Dose-Response Relationship, Drug; Fluorodeoxyglucose F18; Follow-Up Studies; Functional Laterality; Humans; Informed Consent; Levodopa; Parkinson Disease; Positron-Emission Tomography; Preoperative Care; Radiography; Radiopharmaceuticals; Subthalamic Nucleus | 2006 |
Striatal delivery of CERE-120, an AAV2 vector encoding human neurturin, enhances activity of the dopaminergic nigrostriatal system in aged monkeys.
Topics: Aging; Animals; Corpus Striatum; Dependovirus; Disease Models, Animal; Dopamine; Female; Fluorodeoxyglucose F18; Macaca mulatta; Neurturin; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; Substantia Nigra | 2007 |
Changes in network activity with the progression of Parkinson's disease.
Topics: Aged; Blood Glucose; Brain; Brain Mapping; Corpus Striatum; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Longitudinal Studies; Male; Middle Aged; Nerve Net; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; Severity of Illness Index | 2007 |
Metabolic alterations in patients with Parkinson disease and visual hallucinations.
Topics: Aged; Brain; Brain Mapping; Cerebrovascular Circulation; Energy Metabolism; Female; Fluorodeoxyglucose F18; Functional Laterality; Glucose; Hallucinations; Humans; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Predictive Value of Tests; Visual Cortex; Visual Pathways | 2007 |
Comparison of brain MRI and 18F-FDG PET in the differential diagnosis of multiple system atrophy from Parkinson's disease.
Topics: Aged; Brain; Brain Mapping; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Multiple System Atrophy; Parkinson Disease; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies | 2007 |
Metabolic-dopaminergic mapping of the 6-hydroxydopamine rat model for Parkinson's disease.
Topics: Animals; Behavior, Animal; Cocaine; Disease Models, Animal; Dopamine; Dopamine Plasma Membrane Transport Proteins; Female; Fluorodeoxyglucose F18; Glucose; Humans; Oxidopamine; Parkinson Disease; Positron-Emission Tomography; Rats; Rats, Wistar; Tyrosine 3-Monooxygenase | 2008 |
A comparison of cerebral glucose metabolism in Parkinson's disease, Parkinson's disease dementia and dementia with Lewy bodies.
Topics: Aged; Aged, 80 and over; Brain Mapping; Cerebral Cortex; Dementia; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Functional Laterality; Glucose; Humans; Image Processing, Computer-Assisted; Lewy Body Disease; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Predictive Value of Tests; Sensitivity and Specificity | 2007 |
Biomarkers to detect central dopamine deficiency and distinguish Parkinson disease from multiple system atrophy.
Topics: 3,4-Dihydroxyphenylacetic Acid; Analysis of Variance; Biomarkers; Brain; Dihydroxyphenylalanine; Dopamine; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Heart Septum; Humans; Male; Multiple System Atrophy; Parkinson Disease; Positron-Emission Tomography; Sensitivity and Specificity | 2008 |
Subthalamic nucleus stimulation affects orbitofrontal cortex in facial emotion recognition: a PET study.
Topics: Case-Control Studies; Deep Brain Stimulation; Facial Expression; Fear; Female; Fluorodeoxyglucose F18; Frontal Lobe; Glucose; Humans; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Positron-Emission Tomography; Recognition, Psychology; Statistics, Nonparametric; Subthalamic Nucleus | 2008 |
Patterns of cerebral glucose utilization in Parkinson's disease and Huntington's disease.
Topics: Adolescent; Adult; Aged; Brain; Caudate Nucleus; Deoxyglucose; Fluorodeoxyglucose F18; Glucose; Humans; Huntington Disease; Middle Aged; Parkinson Disease; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1984 |
Local cerebral glucose utilisation in treated and untreated patients with Parkinson's disease.
Topics: Antiparkinson Agents; Autoradiography; Blood Glucose; Brain; Deoxyglucose; Drug Therapy, Combination; Fluorodeoxyglucose F18; Humans; Kinetics; Levodopa; Male; Middle Aged; Parkinson Disease; Tomography, Emission-Computed | 1984 |
Patterns of local cerebral glucose utilization determined in Parkinson's disease by the [18F]fluorodeoxyglucose method.
Topics: Aged; Brain; Dementia; Deoxyglucose; Fluorodeoxyglucose F18; Glucose; Humans; Middle Aged; Parkinson Disease; Tomography, Emission-Computed | 1984 |
Complementary positron emission tomographic studies of the striatal dopaminergic system in Parkinson's disease.
Topics: Adult; Aged; Carbon Radioisotopes; Caudate Nucleus; Corpus Striatum; Deoxyglucose; Dihydroxyphenylalanine; Dopa Decarboxylase; Dopamine; Dopamine Antagonists; Energy Metabolism; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Parkinson Disease; Putamen; Raclopride; Receptors, Dopamine D2; Salicylamides; Tomography, Emission-Computed | 1995 |
Early differential diagnosis of Parkinson's disease with 18F-fluorodeoxyglucose and positron emission tomography.
Topics: Adult; Aged; Deoxyglucose; Diagnosis, Differential; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Parkinson Disease; Tomography, Emission-Computed | 1995 |
Clinical/metabolic correlations in multiple system atrophy. A fludeoxyglucose F 18 positron emission tomographic study.
Topics: Atrophy; Brain Diseases; Corpus Striatum; Deoxyglucose; Female; Fluorodeoxyglucose F18; Glucose; Humans; Levodopa; Male; Middle Aged; Olivopontocerebellar Atrophies; Parkinson Disease; Substantia Nigra; Tomography, Emission-Computed | 1995 |
Assessment of disease severity in parkinsonism with fluorine-18-fluorodeoxyglucose and PET.
Topics: Adult; Aged; Brain; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Parkinson Disease; Severity of Illness Index; Tomography, Emission-Computed | 1995 |
Metabolic topography of the hemiparkinsonism-hemiatrophy syndrome.
Topics: Adult; Atrophy; Brain; Deoxyglucose; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Parkinson Disease; Syndrome; Tomography, Emission-Computed | 1994 |
Positron emission tomography in hemiparkinsonism-hemiatrophy syndrome.
Topics: Adult; Aged; Atrophy; Blood Glucose; Brain; Deoxyglucose; Dominance, Cerebral; Energy Metabolism; Facial Hemiatrophy; Female; Fluorodeoxyglucose F18; Hemiplegia; Humans; Middle Aged; Neurologic Examination; Parkinson Disease; Tomography, Emission-Computed | 1993 |
Striatal hypometabolism distinguishes striatonigral degeneration from Parkinson's disease.
Topics: Aged; Brain; Corpus Striatum; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Kinetics; Male; Middle Aged; Organ Specificity; Parkinson Disease; Reference Values; Substantia Nigra; Tomography, Emission-Computed | 1993 |
Regional metabolic correlates of surgical outcome following unilateral pallidotomy for Parkinson's disease.
Topics: Aged; Brain; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Globus Pallidus; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Parkinson Disease; Tissue Distribution; Tomography, Emission-Computed; Treatment Outcome | 1996 |
The metabolic topography of normal aging.
Topics: Adult; Aged; Aged, 80 and over; Aging; Brain; Brain Mapping; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Models, Neurological; Parkinson Disease; Reference Values; Regression Analysis; Tomography, Emission-Computed | 1996 |
Parkinsonian rigidity, dopa-induced dyskinesia and chorea--dynamic studies on the basal ganglia-thalamocortical motor circuit using PET scan and depth microrecording.
Topics: Antiparkinson Agents; Basal Ganglia; Blood Glucose; Brain; Brain Mapping; Cerebral Cortex; Chorea; Deoxyglucose; Dyskinesia, Drug-Induced; Electrodes, Implanted; Energy Metabolism; Fluorodeoxyglucose F18; Globus Pallidus; Humans; Levodopa; Motor Neurons; Neural Pathways; Neurologic Examination; Parkinson Disease; Stereotaxic Techniques; Thalamic Nuclei; Tomography, Emission-Computed; Tremor | 1995 |
Fluoro-deoxyglucose positron emission tomography in diffuse Lewy body disease.
Topics: Aged; Deoxyglucose; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Middle Aged; Parkinson Disease; Prospective Studies; Tomography, Emission-Computed | 1996 |
Secondary parkinsonism due to focal substantia nigra lesions: a PET study with [18F]FDG and [18F]fluorodopa.
Topics: Aged; Deoxyglucose; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Parkinson Disease; Substantia Nigra; Tomography, Emission-Computed | 1996 |
[A case of familial juvenile dystonia-parkinsonism: 18F-6-fluorodopa and 18F-fluoro-2-deoxyglucose PET study].
Topics: Adult; Age of Onset; Brain; Deoxyglucose; Dihydroxyphenylalanine; Dystonia; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Levodopa; Parkinson Disease; Tomography, Emission-Computed | 1996 |
Determination of regional rate constants from dynamic FDG-PET studies in Parkinson's disease.
Topics: Adult; Aged; Biological Transport; Brain; Case-Control Studies; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Hexokinase; Humans; Male; Models, Theoretical; Parkinson Disease; Tomography, Emission-Computed | 1996 |
Regional changes in [18F]dopa metabolism in the striatum in Parkinson's disease.
Topics: Deoxyglucose; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Humans; Middle Aged; Parkinson Disease; Putamen; Tomography, Emission-Computed | 1996 |
Functional effects of striatal dysfunction in Parkinson disease.
Topics: Aged; Basal Ganglia; Corpus Striatum; Deoxyglucose; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Memory; Middle Aged; Movement; Parkinson Disease; Radionuclide Imaging | 1997 |
Cerebral metabolic differences in Parkinson's and Alzheimer's diseases matched for dementia severity.
Topics: Aged; Alzheimer Disease; Brain; Brain Mapping; Case-Control Studies; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Neuropsychological Tests; Parkinson Disease; Stereotaxic Techniques; Tomography, Emission-Computed | 1997 |
Differentiating between multiple system atrophy and Parkinson's disease by positron emission tomography with 18F-dopa and 18F-FDG.
Topics: Adult; Aged; Diagnosis, Differential; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Multiple System Atrophy; Parkinson Disease; Tomography, Emission-Computed | 1997 |
Preoperative indicators of clinical outcome following stereotaxic pallidotomy.
Topics: Aged; Antiparkinson Agents; Brain; Electrophysiology; Female; Fluorodeoxyglucose F18; Globus Pallidus; Glucose; Humans; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Parkinson Disease; Postoperative Period; Stereotaxic Techniques; Tomography, Emission-Computed; Treatment Outcome | 1997 |
Complementary PET studies of striatal neuronal function in the differential diagnosis between multiple system atrophy and Parkinson's disease.
Topics: Aged; Carbon Radioisotopes; Caudate Nucleus; Corpus Striatum; Diagnosis, Differential; Dihydroxyphenylalanine; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Hypotension, Orthostatic; Male; Middle Aged; Multiple System Atrophy; Neurons; Parkinson Disease; Putamen; Raclopride; Radiography; Radiopharmaceuticals; Receptors, Dopamine D2; Regression Analysis; Salicylamides; Tomography, Emission-Computed | 1997 |
Divergent expression of regional metabolic topographies in Parkinson's disease and normal ageing.
Topics: Aging; Analysis of Variance; Brain; Cohort Studies; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Multivariate Analysis; Parkinson Disease; Radiography; Radiopharmaceuticals; Reference Values; Regression Analysis; Severity of Illness Index; Time Factors; Tomography, Emission-Computed | 1997 |
Differential diagnosis of parkinsonism with [18F]fluorodeoxyglucose and PET.
Topics: Aged; Blood Glucose; Brain Mapping; Diagnosis, Differential; Energy Metabolism; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multiple System Atrophy; Parkinson Disease; Parkinson Disease, Secondary; Tomography, Emission-Computed | 1998 |
Asymmetry of basal ganglia glucose metabolism and dopa responsiveness in parkinsonism.
Topics: Adult; Aged; Antiparkinson Agents; Basal Ganglia; Blood Glucose; Brain Mapping; Dominance, Cerebral; Energy Metabolism; Female; Fluorodeoxyglucose F18; Humans; Levodopa; Male; Middle Aged; Motor Skills; Multiple System Atrophy; Neurologic Examination; Parkinson Disease; Tomography, Emission-Computed; Treatment Outcome | 1998 |
Motor correlates of occipital glucose hypometabolism in Parkinson's disease without dementia.
Topics: Aged; Brain Mapping; Dementia; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Occipital Lobe; Parkinson Disease; Tomography, Emission-Computed | 1999 |
Parieto-occipital glucose hypometabolism in Parkinson's disease with autonomic failure.
Topics: Aged; Autonomic Nervous System Diseases; Brain; Brain Mapping; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Occipital Lobe; Parietal Lobe; Parkinson Disease; Radiopharmaceuticals; Tomography, Emission-Computed | 1999 |
Impaired somatosensory discrimination of shape in Parkinson's disease: association with caudate nucleus dopaminergic function.
Topics: Adult; Aged; Brain Mapping; Caudate Nucleus; Discrimination, Psychological; Dopamine; Female; Fluorodeoxyglucose F18; Form Perception; Humans; Male; Middle Aged; Parkinson Disease; Radiopharmaceuticals; Reaction Time; Regression Analysis; Somatosensory Cortex; Tomography, Emission-Computed; Touch | 1999 |
Usefulness of a dopamine transporter PET ligand [(18)F]beta-CFT in assessing disability in Parkinson's disease.
Topics: Aged; Binding, Competitive; Biological Transport, Active; Brain; Caudate Nucleus; Corpus Striatum; Disability Evaluation; Dopamine; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Ligands; Male; Middle Aged; Parkinson Disease; Putamen; Radiopharmaceuticals; Severity of Illness Index; Substantia Nigra; Tomography, Emission-Computed | 1999 |
Cortical dysfunction in non-demented Parkinson's disease patients: a combined (31)P-MRS and (18)FDG-PET study.
Topics: Aged; Case-Control Studies; Dementia; Female; Fluorodeoxyglucose F18; Glucagon; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Occipital Lobe; Oxidation-Reduction; Parkinson Disease; Phosphorus Isotopes; Temporal Lobe; Tomography, Emission-Computed | 2000 |
Fluorodopa uptake and glucose metabolism in early stages of corticobasal degeneration.
Topics: Aged; Basal Ganglia; Brain Diseases; Cerebral Cortex; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Nerve Degeneration; Parkinson Disease; Radiopharmaceuticals; Reference Values; Tissue Distribution; Tomography, Emission-Computed | 1999 |
Acute effects of thalamotomy and pallidotomy on regional cerebral metabolism, evaluated by PET.
Topics: Basal Ganglia; Female; Fluorodeoxyglucose F18; Globus Pallidus; Humans; Male; Middle Aged; Parietal Lobe; Parkinson Disease; Postoperative Care; Prefrontal Cortex; Preoperative Care; Stereotaxic Techniques; Thalamus; Tomography, Emission-Computed | 2000 |
Nigrostriatal dopamine system and motor lateralization.
Topics: Adult; Brain; Case-Control Studies; Dopamine; Female; Fluorodeoxyglucose F18; Functional Laterality; Humans; Male; Middle Aged; Motor Cortex; Neostriatum; Parkinson Disease; Psychomotor Performance; Radiopharmaceuticals; Regression Analysis; Severity of Illness Index; Tomography, Emission-Computed | 2000 |
Correlation of intellectual impairment in Parkinson's disease with FDG PET scan.
Topics: Aged; Brain; Brain Mapping; Cognition Disorders; Female; Fluorodeoxyglucose F18; Functional Laterality; Humans; Image Processing, Computer-Assisted; Intelligence; Male; Memory; Mental Status Schedule; Middle Aged; Parkinson Disease; Radiopharmaceuticals; Tomography, Emission-Computed | 2000 |
FDG- and Dopa-PET in postencephalitic parkinsonism.
Topics: Aged; Diagnosis, Differential; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Parkinson Disease; Parkinson Disease, Postencephalitic; Radiopharmaceuticals; Reference Values; Tomography, Emission-Computed | 2000 |
Hypermetabolism in the ventrolateral thalamus in unilateral Parkinsonian resting tremor: a positron emission tomography study.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Male; Middle Aged; Parkinson Disease; Radiopharmaceuticals; Tomography, Emission-Computed; Tremor; Ventral Thalamic Nuclei | 2001 |
Networks mediating the clinical effects of pallidal brain stimulation for Parkinson's disease: a PET study of resting-state glucose metabolism.
Topics: Adult; Electric Stimulation; Female; Fluorodeoxyglucose F18; Globus Pallidus; Glucose; Humans; Male; Middle Aged; Nerve Net; Parkinson Disease; Radiopharmaceuticals; Tomography, Emission-Computed | 2001 |
Functional decline in Parkinson disease.
Topics: Adolescent; Adult; Age of Onset; Aged; Aged, 80 and over; Autonomic Nervous System Diseases; Demography; Dihydroxyphenylalanine; Disease Progression; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Middle Aged; Multiple System Atrophy; Multivariate Analysis; Neurologic Examination; Parkinson Disease; Radiopharmaceuticals; Time Factors | 2001 |
Metabolic changes following subthalamotomy for advanced Parkinson's disease.
Topics: Adult; Cerebellar Nuclei; Female; Fluorodeoxyglucose F18; Globus Pallidus; Glucose; Humans; Male; Middle Aged; Parkinson Disease; Pons; Radiopharmaceuticals; Subthalamic Nucleus; Thalamus; Tomography, Emission-Computed; Treatment Outcome | 2001 |
Metabolic correlates of levodopa response in Parkinson's disease.
Topics: Aged; Blood Glucose; Brain; Brain Mapping; Energy Metabolism; Female; Fluorodeoxyglucose F18; Humans; Levodopa; Male; Middle Aged; Neurologic Examination; Parkinson Disease; Reference Values; Tomography, Emission-Computed | 2001 |
Resting regional cerebral glucose metabolism in advanced Parkinson's disease studied in the off and on conditions with [(18)F]FDG-PET.
Topics: Adult; Antiparkinson Agents; Case-Control Studies; Cerebral Cortex; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Glucose; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Predictive Value of Tests; Radiopharmaceuticals; Severity of Illness Index; Tomography, Emission-Computed | 2001 |
Guidelines for brain radionuclide imaging. Perfusion single photon computed tomography (SPECT) using Tc-99m radiopharmaceuticals and brain metabolism positron emission tomography (PET) using F-18 fluorodeoxyglucose. The Belgian Society for Nuclear Medicin
Topics: Acetazolamide; Adult; Brain; Brain Death; Cerebrovascular Disorders; Child; Craniocerebral Trauma; Dementia; Diagnosis, Differential; Epilepsy; Fasting; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Parkinson Disease; Radiopharmaceuticals; Subarachnoid Hemorrhage; Technetium; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2001 |
Relationships among the metabolic patterns that correlate with mnemonic, visuospatial, and mood symptoms in Parkinson's disease.
Topics: Adult; Aged; Brain; Brain Mapping; Female; Fluorodeoxyglucose F18; Functional Laterality; Glucose; Humans; Least-Squares Analysis; Male; Memory Disorders; Middle Aged; Models, Neurological; Mood Disorders; Multivariate Analysis; Neuropsychological Tests; Parkinson Disease; Tomography, Emission-Computed | 2002 |
Regional cerebral glucose metabolism in patients with Parkinson's disease with or without dementia.
Topics: Aged; Brain; Dementia; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Parkinson Disease; Tomography, Emission-Computed | 1992 |
Hemi-parkinsonism in multiple system atrophy: a PET and MRI study.
Topics: Adult; Aged; Atrophy; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Organ Specificity; Parkinson Disease; Reference Values; Tomography, Emission-Computed | 1992 |
Positron emission tomography in degenerative disorders of the dopaminergic system.
Topics: Adult; Aged; Alzheimer Disease; Basal Ganglia; Brain; Brain Stem; Deoxyglucose; Dihydroxyphenylalanine; Dopamine; Female; Fluorodeoxyglucose F18; Frontal Lobe; Glucose; Humans; Male; Middle Aged; Parietal Lobe; Parkinson Disease; Supranuclear Palsy, Progressive; Tomography, Emission-Computed | 1992 |
A regional covariance approach to the analysis of functional patterns in positron emission tomographic data.
Topics: AIDS Dementia Complex; Analysis of Variance; Brain; Brain Diseases; Cerebellar Diseases; Data Interpretation, Statistical; Deoxyglucose; Fluorodeoxyglucose F18; Glucose; Humans; Kinetics; Mathematics; Paraneoplastic Syndromes; Parkinson Disease; Tomography, Emission-Computed | 1991 |
The metabolic anatomy of Parkinson's disease: complementary [18F]fluorodeoxyglucose and [18F]fluorodopa positron emission tomographic studies.
Topics: Adult; Brain; Deoxy Sugars; Deoxyglucose; Dihydroxyphenylalanine; Energy Metabolism; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Parkinson Disease; Tomography, Emission-Computed | 1990 |
[Positron emission tomography and basal ganglia functions].
Topics: Animals; Basal Ganglia; Basal Ganglia Diseases; Corpus Striatum; Deoxyglucose; Dopamine; Energy Metabolism; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Macaca mulatta; Mice; Parkinson Disease; Rats; Supranuclear Palsy, Progressive; Tomography, Emission-Computed | 1990 |
Brain glucose metabolism in Parkinson's disease.
Topics: Aged; Blood Glucose; Brain; Brain Mapping; Dementia; Deoxyglucose; Energy Metabolism; Fluorodeoxyglucose F18; Humans; Parkinson Disease; Tomography, Emission-Computed | 1990 |
[Comparison study of positron emission tomography, X-ray CT and MRI in parkinsonism with dementia].
Topics: Aged; Aged, 80 and over; Brain; Dementia; Deoxy Sugars; Deoxyglucose; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Parkinson Disease; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1989 |
Positron emission tomography in Parkinson's disease: glucose and DOPA metabolism.
Topics: Adult; Aged; Blood Glucose; Brain; Caudate Nucleus; Cerebellum; Deoxyglucose; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Humans; Levodopa; Middle Aged; Parkinson Disease; Putamen; Tomography, Emission-Computed | 1987 |
Local cerebral glucose utilization in symptomatic and presymptomatic Huntington's disease.
Topics: Adolescent; Adult; Alzheimer Disease; Brain; Caudate Nucleus; Deoxyglucose; Fluorodeoxyglucose F18; Glucose; Humans; Huntington Disease; Middle Aged; Parkinson Disease; Putamen; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1985 |